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ABSTRACT

INTERACTIONS BETWEEN MALARIA (PLASMODIUM YOELII)
AND LEISHMANIASIS (LEISHMANIA MEXICANA AMAZONENSIS),
WITH A NOTE ON THE BLOOD-FEEDING BEHAVIOR OF
LUTZOMYIA LONGIPALPIS.
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Russell E.

1988)
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Directed by:

Professor John D.

Edman

Evidence has suggested that delicate immunological balances
that normally prevent establishment of Leishmania infections are up¬
set following stress (i.e., malaria),
clinical leishmaniasis.

resulting in the development of

This study was undertaken to determine 1)

whether concomitant infection with Plasmodium yoelii would result in
more severe Leishmania mexicana infection 2) whether immunomodulating
agents would affect the development of these parasites,

3) whether

chemotherapy directed at L. mexicana would affect the progression of
P. yoelii,

and 4) whether host anti-vector defensive behavior would

be affected during concomitant infections.
Laboratory mice were infected with L. mexicana and P.

yoelii.

These mice developed more severe infections than did animals infected
with either parasite alone.

Maximum disease enhancement resulted

when the interval between the inoculation of the two parasites was
minimized.

Several C/57 mice infected with both pathogens developed

v i I

disseminated L. mexicana infections.

Dissemination was never

observed in control mice.
Leishmania mexicana infected mice were treated with immunomodulating agents.

Cimetidine,

were as effective as pentostam,
parasite development.

ranitidine,

and 2'-deoxyguanosine

an antileishmanial agent,

at limiting

Plasmodium yoelii infected mice which were

treated with pentostam developed more severe malaria than did cim¬
etidine treated mice or control animals.

Both agents limited L.

mexicana development in mice infected with both L. mexicana and P.
yoelii; however,

cimetidine reduced P.

yoelii infection in these mice

whereas pentostam increased the severity of the malaria.
Mosquitoes (Aedes aegypti) were unable to feed on uninfected
mice or on mice infected with either P. yoelii or L. mexicana.
Significantly more mosquitoes engorged on mice infected with both
pathogens.

Maximum engorgement occurred during the crisis phase of

the enhanced malarial infection.

Other parameters which were exam¬

ined were altered during peak malarial infection in these dually
infected animals.
Results of this study indicate that concomitant infection with
PIasmodium yoe1ii and Leishmania mexicana can influence parasite
development in laboratory mice.
affected,
tions.
ease.

Not only were clinical symptoms

but vector feeding success was enhanced during dual infec¬

These factors may be critical to the epidemiology of the dis¬
The efficacy of certain chemotherapeutic agents was also

markedly affected in these dually infected animals.
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Chapter 1

LITERATURE REVIEW

Malaria

Malaria is caused by protozoan parasites belonging to the genus
Plasmodium (Family Plasmodiidae).

These organisms undergo two stages

of asexual reproduction (schizogony)

in the vertebrate host and one

stage of sexual reproduction (sporogony)

in the mosquito vector.

Asexual reproduction initially occurs in the parenchymal cells of the
liver,

followed by a subsequent erythrocytic cycle (Bruce-Chwatt

1985).
There are approximately 120 recognized Plasmodium;
only P.

falciparum, P. vivax, P.

(Garnham 1966 1980).
reptiles, primates,

ovale,

and P. malariae infect humans

The remaining species are parasites of birds,
rodents,

bats,

and various other small mammals

(Bruce-Chwatt 1985, Killick-Kendrick & Peters 1978).

Sixty species

of anopheline mosquitoes (Diptera: Culicidae) transmit P.
P. vivax, P.

ovale,

of these,

falciparum,

and P. malariae to humans (Bruce-Chwatt 1970,

Garnham 1966).
Clinical symptoms of malaria typically include fever and anemia
(Aikawa et al.

1974, Maegraith 1977,

1981).

Anemia results primarily

from the destruction of parasitized erythrocytes,

1

although decreased

2

production of red blood cells by the bone marrow contributes to the
decreased hematocrit (Pasvol & Wilson 1982,

Seed & Kreier 1980).

Fever presumably results from the release of endogenous pyrogen from
leucocytes in response to the production of toxic products of the
parasite.

The pyrogen interacts with receptors on the hypothalamus,

resulting in the release of prostaglandin and monoamines.

These

agents signal sympathetic nerve fibers to constrict peripheral blood
vessels (Bruce-Chwatt 1985, Evered & Whelan 1983).

Leishmaniasis

Leishmaniasis is a vector-borne disease that occurs on all con¬
tinents except Australia and Antarctica (Zuckerman & Lainson 1977).
Leishmaniasis is transmitted by various phlebotomine sand flies
(Diptera: Psychodidae)

in the genera Phlebotomus and Lutzomyia (Lewis

1974, Ward 1977 1985).

Estimates on the annual incidence of the dis¬

ease range from 400,000 (Chance 1981) to 12 million (Walsh & Warren
1979) human cases.

The disease is primarily a zoonosis, with the ex¬

ception of visceral leishmaniasis in India and on the east coast of
China (Chang et al.

1985).

Leishmaniasis is caused by parasites belonging to the protozoan
genus Leishmania Ross 1903 (Family: Trypanosoraatidae)
1985).

(Chang et al.

The Leishmania are taxonomically separated into 2 distinct

groups, the Peripylaria and the Subpylaria, which are differentiated
according to the position of the parasite within the vector (Lainson
& Shaw 1979).

Six species of Leishmania infect humans:

Leishmania

3

mexicana, L. major, L. donovoni,

L.

braziliensis,

aethiopica (Molyneux & Ashford 1983).

L.

tropica,

and L.

The parasite exists as an ex¬

tracellular flagellated form in the digestive tract of phlebotomine
sand flies and as a non-motile amastigote in the macrophage of the
vertebrate host (Molyneux & Ashford 1983).
by the sand fly during feeding.

Amastigotes are taken up

The amastigotes differentiate into

promastigotes and begin to divide soon after ingestion.

The para¬

sites initially colonize the midgut or hindgut of the fly (KillickKendrick et al.

1974, Rioux et al.

1979).

Colonization subsequently

extends forward until the pharynx is reached. There,

promastigotes

attach to the cuticle (Killick-Kendrick 1979, Killick-Kendrick et al.
1974, Walters et al.

1987).

the proboscis of the fly,

Promastigotes can eventually be found in

from where they find their way into the

skin of the mammalian host during feeding (Chang et al.

1985).

mastigotes are initially non-infective to the vertebrate;

Pro-

however,

sequential development leads to the production of infective forms
(Sacks & Perkins 1984,

1985).

Numerous studies have shown that infected sand flies have dif¬
ficulty in obtaining blood (Adler & Ber 1941, Chung et al.
Strangways-Dixon & Lainson 1966, Williams 1966).
al.

1951,

Killick-Kendrick et

(1977) observed that infected sand flies took second and third

blood meals with great difficulty,

and Killick-Kendrick and Molyneux

(1981) suggested that promastigotes interfered with sensilla control¬
ling probing and engorgement.

Sensilla in the proboscis have been

described by Killick-Kendrick and Molyneux (1981),
described the cibarial sensilla of sand flies.

and Lewis

(1984)

Interference with the

4

sensilla could result in parasite detachment from the pharynx and
lead to their deposition in the skin of the host.

Recent studies

have clearly shown that vector probing ability is altered when para¬
sites are present (Beach et al.
1985).

1984,

1985, Killick-Kendrick et al.

Congestion of parasites at the stomodeal valve and in the an¬

terior foregut may result in a backwash of blood during feeding,
resulting in the egestion of parasites (Jefferies et al.

1986,

Warburg & Schlein 1986).
Once in the host,

invading promastigotes are rapidly taken up

by macrophages, where transformation to the amastigote form occurs.
Parasites rapidly divide and the macrophage eventually ruptures,

re¬

leasing the parasites into the tissue from where they invade fresh
cells (Molyneux & Ashford 1983).
Three distinct forms of leishmaniasis occur in humans.
are visceral leishmaniasis,

cutaneous leishmaniasis,

neous leishmaniasis (Marsden & Jones 1985).

1981) or L. donovoni chagasi.

of proraastigotes by the sand fly vector,
by macrophages in the liver,

spleen,

and mucocuta¬

Visceral leishmaniasis

is caused by L. donovoni donovoni (Naik 1979), L.
(Bettini et al.

These

donovoni infantum

Following inoculation

the parasites are taken up

bone marrow,

and lymph nodes.

The characteristic clinical symptom at this stage of infection is an
intermittent fever•

The disease rapidly progresses unless appropri¬

ate therapy is initiated.

Symptoms during advanced infection include

prolonged fever and hepatosplenomegaly.

Death normally results from

bacterial sepsis or hemorrhage (Marsden & Jones 1985).
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Cutaneous leishmaniasis is caused by several species of Leishmania,

including L. mexicana, L.

braziliensis,

major (Lainson & Shaw 1973, Manson-Bahr 1971).

L.

tropica,

and L.

As with other forms

of leishmaniasis, promastigotes are inoculated into the skin by sand
flies.

Amastigotes are taken up by macrophages, undergo division,

rupture the cell,

and are taken up by fresh macrophages.

The host

mounts an immune response in which an initial invasion of polymor¬
phonuclear leukocytes is followed by an infiltration of lymphocytes.
Ulceration results from a combination of cellular infiltration,
edema,

and vasculitis,

leading to a poor blood supply and necrosis

(Marsden & Jones 1985).

Blood stream dissemination of parasites oc¬

curs rarely.
Leishmania braziliensis braziliensis is the primary pathogen
responsible for mucocutaneous leishmaniasis.

Parasites metastasize

from an original skin lesion to the blood vessels around the nasal
septum.

Parasites may then spread to the buccal cavity,

pharynx,

and

larynx (Molyneux & Ashford 1983).

Parasite Interactions

Despite extensive control efforts, vector-borne diseases remain
an immense obstacle to social and economic development in the tropics
(BOSTID 1983).
panosomiasis,

Malaria,

filariasis (including onchoceriasis),

try¬

and leishmaniasis debilitate hundreds of millions of

people annually and have resisted most of our control efforts.
resurgence of malaria is of particular concern,

The

and malaria is now
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considered endemic or epidemic throughout much of Africa,

southern

Asia,

and South and Central America.

(WHO)

initiated its campaign to eradicate malaria in 1956,

1970,

727 million people were no longer at risk from malaria (WHO

1979).

The World Health Organization
and by

As recently as 1978, popular literature had reported that

malaria had been wiped out (Phillips 1983);
further from the truth.

however,

nothing could be

In Africa, where the WHO eradication program

was never implemented, malaria control efforts have had little suc¬
cess,

and malaria remains an indigenous problem to the general

population.

In other countries,

initial success has been replaced

with a dramatic resurgence of malaria (Bruce-Chwatt 1985).
resistant Plasmodium,

Drug

insecticide resistant Anopheles mosquitoes,

poor anti-mosquito control measures,

as well as financial and admin¬

istrative shortcomings have all led to this rebound (WHO 1979).
Lanka,

India, Pakistan, Bangladesh,

Sri

and Turkey are notable for the

rising incidence of malaria following the almost total elimination of
the disease in these countries (WHO 1983).
Resurgence of malaria in these third-world countries has led to
an increased number of problems which can be directly attributed to
malaria outbreaks,

such as increased medical costs,

limited fiscal resources,

and loss of labor.

depletion of

Lower infant birth

rates and higher rates of prenatal mortality have been reported
(Brabin 1983, Bray & Anderson 1979, Bruce-Chwatt 1983,

Gilles et al.

1969, Jelliffe 1968), while the incidence of lymphoma's has increased
greatly in malaria endemic areas (Salaman 1970).
malaria,

Indirect effects of

such as interaction with concomitant pathogens,

have been

7

reported.

Historically,

suppression of Treponema pallidum,

a

causative organism of neurosyphilis, via malarial febrile paroxyms,
was a noted medical benefit of pathogen interaction (Bruce-Chwatt
1985).
Enhancement,

as well as suppression,

of concomitant infections

has also been attributed to Plasmodium infection.
diseases,

such as leishmaniasis,

trypanosomiasis,

coincide geographically with malaria.
course of these diseases,

Many infectious
and shistosomiasis,

Malaria may influence the

changing an otherwise non-lethal infection

into one with serious sequelae.

Children infected with P.

falciparum

are abnormally susceptible to bacterial infections (Greenwood et al.
1971),

and malaria has been shown to exert an effect on murine onco¬

genic viruses (Salaman et al.

1969), granuloma formation by Shisto-

soma mansoni (Abdel-Wahab et al.

1974, Lwin et al.

1982),

and on the

spontaneous invasion of tissue by Giardia muris (Radelescu et al.
1971).

Numerous other studies have corroborated the enhancing role

Plasmodium infections can have on concurrent microbial infections
(Bomford & Wedderburn 1973, Thurston 1955,

Strickland et al.

1972).

The immunosuppressive role of malaria appears to be almost en¬
tirely responsible for these enhanced infections (Killick-Kendrick &
Peters 1978).

Immunosuppressive effects of malaria have been docu¬

mented in a number of laboratory studies (Freeman 1978,
al.

1971, Khansari et al.

Greenwood et

1981, Lelchuk & Playfair 1980);

however,

the mechanism has not been entirely elucidated (Khansari et al.
1981).

Suppression of humoral responses is clear (Barker 1971);

role of cell-mediated immunosuppression less so (Zuckerman 1977).

the
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The rodent malaria, P.

berghei,

purportedly exerts its immunosuppres¬

sive effect by an action either on bone-marrow derived lymphocytes or
on macrophages (Greenwood et al.

1971).

More recently,

suppressor

cells derived from T and macrophage lineages have been implicated
(Weinbaum et al.

1978, Correa et al.

substances (Khansari et al.

1981).

1980),

as have soluble secreted

Functional impairment of relevant

immunological cells may also result in immunosuppression (Greenwood
et al.

1971, Loose et al.

1972, Wedderburn 1974).

Additional

research is needed before the precise mechanism of Plasmodium
mediated immunosuppression is determined.
Leishmaniasis coincides geographically with human malaria in
numerous areas of the world (WHO 1984, Harwood & James 1979).
dence suggests that species of Leishmania,
species,

Evi¬

as well as Plasmodium

exert strong immunosuppressive effects (WHO 1984).

Suppres¬

sion of cellular immunity mediated by macrophages and sensitized T
cells appears to be the primary mechanism of Leishmania mediated im¬
munosuppression (Howard et al.
1985c).

Unlike malaria,

1980, Nickol & Bonventre 1985a 1985b

leishmaniasis is primarily and endemic dis¬

ease with normally localized occurrence.

In humans, many Leishmania

infections terminate subclinically (Molyneux & Ashford 1983, WHO
1984).

Studies have indicated that exposure to L.

donovoni does not

necessarily result in clinical symptoms (Fuller et al.
Pampiglione et al.

1974).

Up to 64% of individuals examined in

Ethiopia tested positive for the Leishmanin skin test.
2 of the 2723 individuals tested had active L.
(Fuller et al.

1979).

1979,

However,

only

donovoni infections

This suggests a high incidence of cryptic
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infections (Fuller et al.

1979).

Circumstantial evidence suggests

that delicate immunological balances that normally prevent establish¬
ment of Leishmania infections are commonly upset following stress
(e.g.,

famine, war,

and epidemic malaria) and result in the develop¬

ment of clinical leishmaniasis (Corkill 1948).
The potential for both concurrent and asynchronous Plasmodium Leishmania infections readily exists,
graphic ranges and seasonal patterns.

based on their respective geo¬
Geographic overlap,

in con¬

junction with the known immunosuppressive effects of each parasite,
suggests that concurrent Plasmodium and Leishmania infections could
each suppress immune function.

This would theoretically increase the

severity of the complementary disease.
following recovery from acute P.
strated (Greenwood et al.

Decreased immunocompetence

falciparum infection has been demon¬

1972, McGregor 1972).

Hence,

dual infec¬

tions need not be simultaneous in order for disease enhancement of
occur.
The incidence of leishmaniasis has been shown to decrease
markedly in areas where intensive malaria control efforts are imple¬
mented (Molyneux & Ashford 1983).

Elimination of endophilic sand

flies due to the use of residual pesticides directed at Anopheles
mosquitoes has been suggested as the primary cause of this decrease.
However,

epidemiological evidence suggests that leishmaniasis is pre¬

dominantly a rural disease.
sonnel, woodcutters,

hunters,

High risk groups include military per¬
etc.,

indicating that endophilic sand

flies are probably not the primary vectors of leishmaniasis in many
instances.

We suggest that it may be the absence of Plasmodium
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infections (resulting from malarial control efforts),
elimination of suitable vectors,

rather than the

that resulted in the corresponding

decrease in the incidence of clinical cases of leishmaniasis.
In the only experimental study of dual malaria - leishmaniasis
infections,

the interactions between P.

berghei and L.

examined in the golden hamster (Adler 1954).
normally lethal P.

infantum was

Protection against the

berghei was found in hamsters previously infected

with a virulent strain of L.

infantum.

Infection with P.

not inhibit or promote multiplication of L.

infantum.

berghei did

The model used

by Adler is not directly applicable to typical human infections,
both L.

infantum and P.

as

berghei are more highly virulent in the ham¬

ster than any human Plasmodium of Leishmania species.

Chemothe rapy

Malaria
Different species of Plasmodium vary in their susceptibility to
antimalarial drugs,

and not all life stages are affected by a given

agent (Rieckmann & Silverman 1977).

Drugs used for the treatment of

malaria can be divided into two major groups of compounds,

i) prophy¬

lactic agents, which prevent the establishment of the parasite in the
liver,

and ii) schizonticides, which attack the parasites in the red

blood cell (Bruce-Chwatt 1985).

Compounds which are effective anti-

malarial agents include antifolates,
lines,

artemisinine,

8-aminoquinolines,

4-arainoquino-

and various antibiotics (WHO 1984b).

Chinchona alkaloids,

and in particular quinine,

have been used

to treat malaria for over 300 years (Bruce-Chwatt 1985).

Various new

agents which have been synthesized in recent years have largely re¬
placed quinine; however,

as the incidence of drug resistant Plasmod¬

ium increases, use of quinine is increasing.

Quinine is primarily

used in treating severe cases of malaria that do not respond to other
agents.

Prolonged administration of quinine can result in signifi¬

cant side-effects (Rieckmann & Silverman 1977).
The 8-aminoquinolines are active against primary tissue stages,
hypnozoites (those liver forms that result in parasite relapse),
metocytes,

and asexual blood stages (WHO 1984b).

most widely used 8-aminoquinoline,
ment or prevention of malaria.
prevent relapses of malaria,

Primaquine,

ga-

the

is not used alone for the treat¬

This agent is primarily used i) to

or ii)

in conjunction with other agents

to prevent the spread of drug resistant parasites (Bruce-Chwatt
1985).
Chloroquine,
malarial drug.

a 4-aminoquinoline,

is the most widely used anti-

Its initial success was an important component of the

WHO global malaria eradication campaign,

and the spread of resistance

to the compound contributed to the demise of the program (Moore &
Lanier 1961, Harinasuta et al.

1962).

Chloroquine is effective both

as a blood schizontocide and as a prophylactic agent and also de¬
stroys gametocytes of P. vivax, P.
falciparum.

ovale,

Side-effects are uncommon.

and P. malariae»

but not P.

The schizontocidal toxicity

of chloroquine results from the selective uptake of the agent by in¬
fected erythrocytes (WHO 1984b).

Chloroquine resistance may result
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from the active efflux of chloroquine from infected erythrocytes,

ef¬

fectively preventing the accumulation of toxic levels of the compound
in the cell (Martin et al.
nel blocker,

1987).

Use of verapamil,

a calcium chan¬

can effectively reverse drug resistance by inhibiting

the efflux of chloroquine from infected erythrocytes (Martin et al.
1987).
Mefloquine is a substituted 4-quinoline methanol that is struc¬
turally similar to quinine.

It is a highly efficient schizonticidal

that is effective against chloroquine,

pyrimethamine resistant P.

falciparum and against P. vivax (Bruce-Chwatt 1985).

Side effects

are minimal at therapeutic doses.
The antifolates include pyrimethamine and proguanil
1984b).

(WHO

These agents inhibit dihydrofolate reductase or dihy-

dropteroate synthetase and are effective against all multiplying
stages of the parasite.

Various antibiotics,

doxycycline,

and clindamycin affect developing liver

lincomycin,

stages and blood stages.

including monocycline,

These agents are inhibitors of ribosomal

protein synthesis in prokaryotes,

and are normally used following

treatment with quinine (WHO 1984b).

Artemisinine (qinghaosu)

is a

sesquiterpene lactone isolated from the plant Artemisia annua.
Quinghaosu is active against chloroquine resistant P.
humans,

falciparum in

and acts synergistically with mefloquine (WHO 1984b).

13

Leishmaniasis
All forms of old world cutaneous leishmaniasis heal sponta¬
neously,

and in the new world,

results in benign lesions.

infection with L. mexicana normally

Treatment of these forms of disease may

not be required unless multiple lesions occur or unless lesions are
located on a cosmetically important site (Marsden & Jones 1985).

Due

to the danger of metastasis and the development of mucocutaneous
leishmaniasis,
treatment.

infection with L.

Likewise,

braziliensis requires mandatory

clinical visceral leishmaniasis can be unifor-

mally fatal unless treatment is initiated (Rees et al.

1985).

All forms of leishmaniasis are initially treated with pentavalent antimony in the form of sodium stibogluconate (pentostam) or Nmethyl glucanime antimonate (glucantime)
action of these agents is unknown.

(Berman 1985).

The mode of

Treatment failure or relapse oc¬

curs in approximately 10-25% of the cases where these agents are used
(Berman 1983).

Therapeutic doses of pentavalent antimonials are also

associated with a variety of toxic side effects.

Malaise,

anorexia,

and vomiting appear early in the treatment, with electrocardiograph
alterations and occasional renal insufficiency (Marsden & Jones
1985).
Secondary treatment for leishmaniasis normally consists of pen¬
tamidine of amphotericin B.
relatively toxic,

However,

these agents are expensive,

and treatments are lengthy (Berman 1985).

Intense

efforts are therefore currently underway to develop new therapeutic
drugs.

Agents which show promise include allopurinol

1981, Walton et al.

1983), nifurtimox (Marsden et al.

(Kager et al.
1979),
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pyrimethamine (Neal 1976), various 8-aminoquinolines (Kinnamon et al.
1978),

and chlorpromazine (Pearson et al.

1982).

The use of liposome-encapsulated agents has greatly reduced the
amount of drug required to treat leishmaniasis (Alving & Swartz 1984,
Reed et al.

1984).

Liposomes are vesicles which form spontaneously

when lipids are dispersed in aqueous media.

Any drugs present in the

media will be partially incorporated into the the aqueous phase
between the lipid rings.

Liposomes are rapidly removed from the

circulatory system by the reticuloendethelial cells of the liver and
spleen (Juliano 1982,

Scherphof 1982).

Therapeutic agents incorpo¬

rated within the liposomes are then available to kill any parasites
within the macrophage,

but are themselves effectively sequestered

from the rest of the body (Black et al.
et al.

1977, New et al.

1978,

Reed

1984).

Immuno-modulation
The use of therapeutic agents which modulate immune responses
could be of great value in the prophylaxis and treatment of infec¬
tious diseases (Drews 1985).

Three classes of compounds which affect

immune function have received widespread attention.

These include

substances which affect purine metabolism in lymphocytes,
H2 blockers,

histamine

and various products of immune cells (Drews 1985).
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Host-Vector Interactions

Vector-borne diseases,

such as leishmaniasis and malaria,

de¬

pend upon the frequency and success of host/vector interactions for
transmission.

Vector contact with an infected host,

take of infected fluid,

and,

after a given period of time,

contact and feeding upon a susceptible host,
cess of transmission.

subsequent

are implicit in the pro¬

These components of arthropod-borne diseases

have received increasing attention (Balashov 1984,
1984a,

successful up¬

1984b, Day et al.

1983, Edman et al.

cal abundance of the vector population,
tions favorable to parasite development,

1972,

Day & Edman 1983,
1974).

The numeri¬

their longevity under condi¬
and the affinity of the

arthropod for vertebrates capable of harboring the parasite are among
the more important characteristics relevant to the transmission pro¬
cess (Reeves 1971).
Host behavior can clearly play an important role in determining
whether a parasite has an opportunity to be transmitted by an arthro¬
pod (Day & Edman 1984b, Edman et al.
& Edman 1985 1986).

1974, Waage & Nondo 1982, Walker

In some instances modification of host behavior

may be induced by a parasite,

resulting in an increased probability

of pathogen transmission (Dawkins 1982).

Rodent defensive behavior

normally prevents mosquitoes from successfully feeding upon them,
thereby eliminating the possibility of disease transmission.

How¬

ever,

or P.

lab mice infected with Plasmodium berghei. P.

chabaudi,

^■°elli exhibited periods of reduced defensive behavior which corre¬
sponded to maximum gametocyte infectivity.

This period did not
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necessarily correspond with maximum parasitemia (Day & Edman 1983a).
Dye and Hasibeder (1986) examined the dynamics of vector-borne dis¬
eases when non-random host/vector contact occurred.
Arthropod behavior may also be manipulated by the parasite in
such a way that transmission of the pathogen is facilitated.

Two op¬

posing processes which affect feeding success, vector contact and
impairment of feeding processes,

are known to promote disease trans¬

mission.
Vector contact with the host is fraught with risks,
due to host defensive behavior.

primarily

Rapid feeding minimizes the period

spent by the vector on the host without sacrificing maximum nutrient
uptake;

this presumably increases vector survival (Daniel & King-

solver 1983, Me11ink 1981).

Arthropods minimize host contact by

releasing antihemostatic salivary components that inhibit platelet
aggregation and enhance blood location (Ribiero et al.
ous vector-borne parasites inhibit host hemostasis.

1984).

Numer¬

This inhibition

contributes to blood-finding success (Rossignol et al.

1985).

Exam¬

ples of alteration of host hemostasis include thrombocytopenia re¬
sulting from malaria, dengue, African trypanosomiasis,
and babesiosis (Allen et al.

leishmaniasis,

1975, Davis 1982, Halstead 1984),

rhagic disorders caused by Rift Valley fever virus,

hemor¬

and vasodilation

resulting from infection with Rocky Mountain spotted fever and en¬
demic typhus (Rossignol et al.
Alternatively,

1985).

impairment of processes affecting feeding may

also facilitate pathogen transmission.

Numerous studies have shown

that parasites can cause pathology to the vector.

Arthropods
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infected with Leishmania (Beach et al.
et al.

1984 1986),

1985),

Plasmodium (Rossignol

and trypanosomes (Anez & East 1984, Jenni et al.

1980) probe more frequently than their uninfected counterparts.
Mosquitoes infected with La Crosse virus have an impaired ability to
feed,

and therefore may contact more hosts during a single

gonotrophic period (Grimstad et al.

1980).

A combination of impaired

probing ability with host defensive behaviors may extend feeding time
and/or increase the number of hosts contacted by an infected insect.

Chapter II

INTERACTIONS BETWEEN PLASMODIUM YOELII AND
LEISHMANIA MEXICANA AMAZONENSIS IN LEISHMANIA
SUSCEPTIBLE BALB/C MICE

Introduction

Human leishmaniasis is a protozoan disease with a wide spectrum
of clinical manifestations (Turk & Bryceson 1971,
1980).

Belehu et al.

Three primary forms of human disease have been described.

Each of these forms may exhibit a variety of symptoms (Molyneux &
Ashford 1983),

ranging from inapparent infections (Pampiglione et al.

1974) to fulminating cases with fatal sequelae (Hill 1986).

The

clinical symptoms that develop in a given individual reflect proper¬
ties of the parasite involved as well as intrinsic host features,
such as genetic background and immunological competence (Blackwell &
Ulczak 1984, Hill 1986,

Semprevivo et al.

1981).

Evidence suggests that clinically apparent cases of leishmania¬
sis, no matter how severe the symptoms are once these cases become
established,

comprise only a small fraction of all actual infections

(Pampiglione et al.

1974, Fuller et al.

1976 1979).

Serological evi¬

dence has shown that cryptic L. donovoni infections are widespread in
Ethiopia (Ayele & Ali 1984, Fuller et al.
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1976,

1979) and Italy
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(Pampiglione et al.

1974), yet clinically evident cases of visceral

leishmaniasis are quite rare in these countries.

American cutaneous

leishmaniasis may occur as a cryptic infection (Gustafson et al.
1985),

and L.

braziliensis has been shown to remain latent for many

years without the development of clinical symptoms (Walton et al.
1973).
The factors which determine whether or not an individual will
develop clinically evident leishmaniasis have not been conclusively
determined.

Laboratory studies have shown that the genetic back¬

ground of the host is important.

Different strains of inbred mice

vary greatly in their response to Leishmania.

Some strains are com¬

pletely resistant to the parasite while others are acutely susceptible (Howard et al.

1980, Perez et al.

1979,

Semprevivo et al.

1981).

The immunological competence of the host also affects disease outcome
(Liew et al.

1982).

The development of leishmaniasis at the site of

inoculation and in metastatic visceral and cutaneous foci is influ¬
enced by host immunity.

Failure of immune function has been sug¬

gested as a primary factor that may lead to the development of
disseminated forms of leishmaniasis (Hill 1986).
Any factor that has the capacity to alter immunological func¬
tion could theoretically affect the course of leishmaniasis.
piglione et al.
malaria,

(1974) suggested that stress,

i.e.

Pam¬

famine or epidemic

could affect the competence of the immune system.

This

could transform an inapparent infection into a clinically evident
case of leishmaniasis.

Walton et al.

(1973) proposed that tubercu¬

losis could upset immunological function,

thereby precipitating the
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invasion of mucosal tissue by L.

braziliensis after many years of

asymptomatic infection.
Outbreaks of visceral leishmaniasis are common following
epidemics of malaria (Pampiglione et al.

1974).

Malaria coincides

geographically with leishmaniasis in many parts of the tropics.
Numerous studies have shown that infection with malaria can result in
the enhancement of concomitant infections,

presumably via an immuno¬

suppressive mechanism (Greenwood 1974, Khansari et al.
Kendrick & Peters 1978, Krettli 1977,
et al.

1982).

1981, Killick-

Lelchuk & Playfair 1980,

Lwin

Malaria-mediated immunosuppression has been implicated

in the development of Burkitt's lymphoma (Salaman 1970),

and loss of

cellular-mediated immunity due to malaria can lead to reactivation of
herpes simplex viruses (Cook 1985).
In the only study on concomitant leishmaniasis and malaria,
Adler (1954) examined interactions between P.

berghei and L.

in the golden hamster, Mesocricetus auratus.

Animals previously

infected with L.
lethal P.

infantum

infantum were somewhat resistant to the normally

berghei.

There was no evidence that either infection was

enhanced in dually infected animals.
The purpose of this study was to determine whether concurrent
infection with malaria would result in enhanced leishmaniasis in
highly susceptible mice.

Interactions between Plasmodium yoelii and

Leishmania mexicana were examined in BALB/c mice.

These mice are a

satisfactory model for progressive cutaneous leishmaniasis (Perez
1983).

The interval between the inoculation of each parasite was
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varied.

This allowed me to examine the role of the timing of inocu¬

lation of each parasite on the course of the concomitant pathogen.

Materials and Methods

Animals
Female BALB/c mice were obtained from the Charles River Breed¬
ing Laboratory, Wilmington, Massachusetts.

Eight-week-old female

mice weighing 25-30 g were used for all experiments.

Malaria
The 17x strain of Plasmodium yoelii was used.
provided by Dr. J. Day.

It was kindly

It is maintained in our laboratory by weekly

passage of infected blood in BALB/c mice.

Inocula were prepared from

red blood cells (RBC) collected in phosphate-buffered saline (PBS)
from the tail of an infected mouse.

The percent of infected RBC were

determined from Giemsa-stained thin blood smears.

A hemocytometer

was used to determine the actual number of RBC per unit volume.
Blood was then diluted with PBS so that each mouse received 1 x 10^
infected RBC i.p.

in 0.2 ml.

The course of infection was monitored

by determining P. yoelii parasitemia in Giemsa-stained blood smears
(the percent of RBC infected with P. yoelii is presented as the
"index of malaria" in all Figures).

Blood smears were prepared every

2 days until no parasites were found over a 6 day period.

All mice

were monitored once a week thereafter to check for possible relapses
of the Plasmodium
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Leishmaniasis
The Walter Reed strain 227 of Leishmania mexicana amazonensis
was used.

The source and history of this isolate have been described

(Nolan et al.

1984).

Amastigotes were obtained from donor mice 7-10

weeks after subcutaneous inoculation of 2 x 106 amastigotes into the
right-rear footpad.
amputated,

The doner was sacrificed and the infected foot

surface sterilized with 70% ETOH,

and homogenized in a

Ten-Broeck glass tissue grinder containing 3-4 ml PBS.
allowed to settle,

Debris was

then the supernatant pipetted off for use.

Amastigote viability was determined using the method of Hodgkinson
and Herman (1980) and the number of parasites per unit volume calcu¬
lated using a Petroff-Housser bacterial cell counting chamber.

The

solution was adjusted with PBS to obtain a final concentration of
either 1 x 10^ or 2 x 10^ viable amastigotes in 10 microliters PBS.
Mice were infected by subcutaneously inoculating 10 microliters of
the appropriate solution into the ventral surface of the right-rearfootpad.

The thickness of the infected footpad was measured once a

week using a direct-reading vernier caliper.

Measurements commenced

1 week prior to the inoculation of L. mexicana and continued for at
least 10 weeks.

Lesion diameter was expressed as the thickness of

the infected footpad in millimeters minus the thickness of the
contralateral uninfected footpad (the mean adjusted lesion diameter
is expressed as the "Index of Leishmaniasis" in all Figures).
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Experimental Design
An initial experiment was designed to test our experimental
protocol for precision and reliability.

Three groups of 30 mice each

were infected with either 1 x 10^ L. mexicana amastigotes,
mexicana amastigotes,

or 1 x 106 P. yoelii infected RBC.

2 x 10^ L.
Mean values

were recorded and plotted.
Five additional experiments were conducted.

The interval be¬

tween the inoculation of the two parasites was varied in each
experiment,
1)

as follows:

P. yoelii followed by L. mexicana in 2 days
(1 x 10^ amastigotes).

2)

P. yoelii followed by L. mexicana in

3 weeks

(2 x 10^ amastigotes).
3)

P. yoelii followed by L. mexicana in 20 weeks
(2 x 10^ amastigotes).
L* mexicana (2 x 10^ amastigotes) followed by
P. yoelii in 3 weeks.
h'

mexicana (2 x 10^ amastigotes) followed by
F. yoelii in 12 weeks.

Four groups of 10 mice each were used for each of the 5 experi¬
ments.

These groups consisted of:

infected mice,

1) uninfected mice,

3) L. mexicana infected mice,

mexicana infected mice.

and 4) P.

2) P.

yoelii

yoelii and L.

Mean P. yoelii parasitemia rate and mean L.

-XiCana lesion size *ere recorded for each group of mice in each ex¬
periment .
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Results

Consistent P. yoelii and L. mexicana infections were produced
in the initial experiment (Figs.

1 & 2).

Based on these results I

believed that similar precision and consistency would be expected
during experiments on dual infections.
Results from the 5 experiments examining interactions between
parasites are shown in Figs.

3-7.

Peak malaria infections with 10-

15% infected RBC's occurred in mice inoculated with P.
None of these mice died.

yoelii only.

When P. yoe 1 ii was preceded by L. mexicana,

the malaria infection was both enhanced and prolonged (Figs 3,
6).

4,

&

Up to 50% of the mice in these groups died.
Two different doses of L. mexicana were used to inoculate mice.

Regardless of the dose, L. mexicana infections were more severe in
those mice where P. yoelii was inoculated at or around the same time
as L. mexicana compared to mice infected with L. mexicana only (Figs.
3, 4, & 5).

This enhancement of the leishmaniasis began within 1-2

weeks following the elimination of P. yoelii from the peripheral
blood and continued for the duration of the infection.

When P.

Xoelii was inoculated 20 weeks prior to L. mexicana no enhancement of
the leishmaniasis occurred (Fig.

7).

Figure 1.
Course of Plasmodium yoelii in 30 BALB/c mice.
Mice were infected on Day 0 (+/- SE).

Time (days)
26

O
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Figure 2.
Course of Leishmania mexicana in BALB/c
mice infected with 1 x 106 or 2 x 10° amastigotes.
Mice
were infected on Week 0 (+/- SE).

Time (weeks)
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Figure 3.
Interactions between Plasmodium yoelii and
Leishmania mexicana in BALB/c mice.
L. mexicana followed
by P. yoelii in two days (+/- SE).

Time (weeks)

Index of leishmaniasis
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Figure 4.
Interactions between Plasmodium yoelii and
Leishmania mexicana in BALB/c mice.
L. mexicana followed
by P. yoelii in three weeks (+/- SE).
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Time (weeks)

Index of leishmaniasis
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Figure

5.

Interactions between Plasmodium yoelii and

Leishmania mexicana
L.

in BALB/c mice.

mexicana in three weeks

(+/- SE).

P.

yoelii followed by

34
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Figure 6.
Interactions between Plasmodium yoelii and
Leishmania mexicana in BALB/c mice.
L. mexicana followed
by P. yoelii in twelve weeks (+/- SE).

36

Index of leishmaniasis
£}

£!

0)

(0

co

O

Time (weeks)

2

O

ro

m
CM

O

C\J

eueieiu jo xepu|

37

Figure 7.
Interactions between Plasmodium yoelii and
Leishmania mexicana in BALB/c mice.
P. yoelii followed by
L. mexicana in twenty weeks (+/- SE).
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Time (weeks)

Index of leishmaniasis
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Discussion

The primary objective of this research was to determine if con¬
comitant infection with malaria would result in more acute leishmani¬
asis in the susceptible BALB/c mouse.
(see Fig.

Results clearly demonstrated

3) that not only did malaria enhance the course of cuta¬

neous leishmaniasis,

but that fatality rates of up to 50% could be

ascribed to the malaria in those mice infected with both L. mexicana
and the normally non-lethal P. yoelii.

These findings suggest that

in those regions of the world where malaria coincides geographically
with leishmaniasis,

clinical incidence and severity of the diseases

in humans also could be influenced by concomitant infections.
Under natural conditions the two infections often may not ini¬
tiate at the same time.

With this in mind,

experiments were designed

to determine the effect if the malaria or leishmaniasis were initi¬
ated well before or after the other infection.

Results presented in

Figs. 4 and 5 clearly demonstrate that the leishmanial infection is
enhanced if the malaria is introduced 3 weeks before or after the
Leishmania inoculation.

Similarly,

the malaria was enhanced in all

cases of concomitant infection (see Figs.
prisingly,

3,

4,

& 6).

Somewhat sur¬

enhancement of P. yoelii parasitemia was minimal when that

parasite was inoculated during advanced L. mexicana infection (Fig.
5).

Existing knowledge indicates that cell-mediated immunity is sup¬

pressed during this stage of the infection (Howard et al.

1981).

the malarial infection was not affected more significantly is not
known.

The most pronounced influenc e of leishmaniasis upon the

Why
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malaria occurred when the former was inoculated only a few days
before the latter (see Fig.

3).

However,

even when the malarial

infection was initiated 3 weeks before the leishmaniasis it had a
strong influence on the leishmanial infection.

In both these situa¬

tions the concomitant infection strongly influenced the capacity of
the host to resist the second infection,

yet the original infections

were either subpatent or apparently eliminated.

Documentation of the

effect of concomitant infections in humans may require not only imme¬
diate examination for dual infections but significant follow-up and
knowledge of the patient's history.
Although the mechanism by which each of these parasitic infec¬
tions enhances the other is not known,

it has been established that

each elicits immune suppressor activity.

In many areas of the world

where multiple parasitic infections in humans may be the rule rather
than the exception,

specific and nonspecific immune suppression re¬

sulting from previous,

concurrent,

or subpatent infections may be of

considerable influence to chemotherapeutic and immunologic interven¬
tion .
These results are in direct contrast to those obtained by Adler
(1954), who found that infection with L.

infantum in the golden ham¬

ster protected against the normally lethal P.

berghei.

Existing

knowledge on the role of cell-mediated immunity during malaria and
leishmaniasis indicates that suppression of immune function should
lead to enhancement, not suppression,

of concomitant infections.

Disease enhancement may be a general phenomenon resulting from concomitant malarial - leishmanial infections.

Chapter III

INTERACTIONS BETWEEN PLASMODIUM YOELII AND
LEISHMANIA MEXICANA AMAZONENSIS IN LEISHMANIA
RESISTANT C/57 MICE

Introduction

Human disease due to infection with Leishmania mexicana nor¬
mally consists of a single lesion which spontaneously heals
al.

1978).

(Perez et

Recovery is usually accompanied by the development of

delayed hypersensitivity response to leishmanin as well as immunity
to reinfection by the parasite.
Various strains of inbred mice are commonly used as experimen¬
tal hosts for L. mexicana (Barrel et al.
Perez et al.

1978,

1979).

1983, Neal & Hale 1983,

Different strains of mice vary greatly in

their responses to L. mexicana.

Some mice (e.g.,

resistant to L. mexicana while others (e.g.,

C/57 strain)

are

BALB/c strain) are

acutely susceptible to the parasite (Perez et al.

1979).

Numerous studies have shown that infection with malaria can
result in the enhancement of concomitant infections,

presumably via

an immunosuppressive mechanism (Greenwood 1974, Khansari et al.
Killick-Kendrick & Peters 1978, Krettli 1977,
1980, Lwin et al.

1982).

1981,

Lelchuk & Playfair

The purpose of this study was to determine
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whether concurrent infection with malaria would result in enhanced
leishmaniasis in a Leishmania-resistant mouse strain.
Interactions between Plasmodium yoelii and L. mexicana amazonensis were examined in C/57 mice.

The interval between the inocula¬

tion of each parasite was varied.

Similar experiments were previ¬

ously conducted in Leishmania—susceptible BALB/c mice;

however,

the

presentation of L. mexicana in BALB/c mice does not reflect the
normal course of the parasite in humans.

In this respect C/57 mice

provide a more realistic model for studying interactions between
malaria and leishmaniasis.

Materials and Methods

Animals
Female C/57 mice were obtained from the Charles River Breeding
Laboratory, Wilmington, Massachusetts.

Eight-week-old mice weighing

25-30 g were used for all experiments.

Malaria
Techniques for inoculating and quantifying P.

yoelii have been

described (Chapter 2).

Leishmaniasis
Techniques for inoculating and quantifying L. mexicana amazon~ns^- have been described (Chapter 2).
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Experimental Design
An initial experiment was designed to test the experimental
protocol for the inoculation and quantification of L. mexicana in
C/57 mice.

Two groups of 30 mice each were infected with either 1 x

10^ or 2 x 10^ L. mexicana amastigotes.

Mean lesion diameters were

recorded.
Five additional experiments were conducted.
between the inoculation of P.
each experiment,
1)

yoelii and L. mexicana was varied in

as follows:

P. yoelii followed by L. mexicana (1 x 10^
amastigotes)

2)

The interval

in 2 day.

P. yoelii followed by L. mexicana (2 x 10^
amastigotes)

3)

in

3 weeks.

P. yoelii followed by L. mexicana (2 x 106
amastigotes)

4)

in 16 weeks.

L. mexicana (2 x 106 amastigotes) followed by
P. yoelii in 3 weeks.

5)

L« mexicana (2 x 10^ amastigotes) followed by
P. yoelii in 12 weeks.

Four groups of 10 mice each were used for each of the 5 experi¬
ments.

These groups consisted of:

infected mice,

1) uninfected mice,

3) L. mexicana infected mice,

mexicana infected mice.

and 4) P.

2) P.

yoelii

yoelii and L.

Mean P. yoelii parasitemia rate and mean L.

mexicana lesion size were recorded for each group of mice in each ex¬
periment .
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Results

Consistent Leishmania infections were produced with both
dosages of L. mexicana in the initial experiment (Fig.

8).

Results

from experiments examining interactions between parasites are shown
in Figures 9-13.

The P. yoelii infection was significantly enhanced

in those instances where L. mexicana was inoculated prior to the
malaria (Figs.

9,

10, & 12).

L. mexicana lesions were greater in

mice where the malaria was inoculated before or slightly after the
leishmaniasis (Figs.

9,

10,

11, & 13).
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_ in C/57
Figure 8.
Course of Leishmania mexicana
mice infected with 1 x 106 or 2 x 106 amastigotes. Mice
were infected on Week 0 (+/- SE).
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Figure 9.
Interactions between Plasmodium yoelii and
Leishmania mexicana in C/57 mice.
L. mexicana followed by
P. yoelii in two days ( + /- SE).
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Time (weeks)

Index of leishmaniasis

49

Figure 10.
Interactions between Plasmodium yoelii and
Leishmania mexicana in C/57 mice.
L. mexicana followed by
P. yoelii in three weeks (+/- SE).
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Figure 11.
Interactions between Plasmodium yoelii and
Leishmania mexicana in C/57 mice.
P. yoelii followed by L.
mexicana in three weeks (+/- SE).
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Figure 12.
Interactions between Plasmodium yoelii and
Leishmania mexicana in C/57 mice.
L. mexicana followed by
P. yoelii in twelve weeks (+/- SE).
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Figure 13.
Interactions between Plasmodium yoelii and
Leishmania mexicana in C/57 mice.
P. yoelii followed by L.
mexicana in twelve weeks (+/- SE).
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Discussion

Previous experiments examined interactions between P.
and L. mexicana in BALB/c mice.

yoelii

BALB/c mice infected with L. mexi-

cana developed fulminating lesions which did not heal.

Infection

with P. yoelii resulted in these mice becoming even more susceptible
to L. mexicana.

Under certain circumstances the presence of L. mexi¬

cana also resulted in more severe malaria compared to mice infected
only with P. yoelii.
In humans, L. mexicana normally produces a single lesion which
heals spontaneously (Perez et al.

1978).

Infection produced by L.

mexicana in BALB/c mice therefore does not provide a comparable model
of human disease.

C/57 mice infected with L. mexicana develop

lesions which initially ulcerate but subsequently heal.

These benign

lesions resemble those normally produced in humans by L. mexicana
(Perez et al.

1979).

Results from the present study support previous conclusions
based on interactions between P. yoelii and L. mexicana in BALB/c
mice.

Plasmodium yoelii parasitemia was markedly enhanced whenever

L. mexicana was inoculated prior to the malaria (Figs.
In BALB/c mice,

9,

10,

& 12).

significant mortality occurred during dual infec¬

tions, whereas no deaths occurred in C/57 mice.

Maximum disease

enhancement occurred when the interval between inoculation of P.
yoelii and L. mexicana was short (Figs.

9 & 10).

As in BALB/c mice,

increased P. yoelii parasitemia occurred prior to the development of
clinically evident leishmaniasis (Fig.

9).
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Surprisingly,

inoculation of L. mexicana followed by P.

yoelii

in 12 weeks produced little enhancement of either the malaria or the
leishmaniasis (Fig.

12).

These results support those in BALB/c mice.

While we have not examined immunological function during dual infec¬
tions,

lesion size decreased after week 8.

This suggests that the

host immune system was actively responding to L. mexicana by 12 weeks
post-inoculation.

Any effect produced by P.

yoelii at this point

might not influence the progression of L. mexicana in the mouse.

It

is also possible that establishment of L. mexicana within the host is
affected by P. yoelii.

Once established,

the course of leishmaniasis

might progress independently of concomitant parasites.
In regions of the world where malaria and leishmaniasis coin¬
cide geographically,

interactions between these parasites may play an

important role in determining disease outcome.

Our results clearly

demonstrate that not only is the clinical infection important in
determining the course of concomitant parasitic infections,
prior patent,

but that

or subpatent infections have the ability to affect

disease outcome as well.

Recognition and treatment of subpatent

infections therefore might be of considerable significance to the
success of primary treatment.

Chapter IV

METASTASIS OF LEISHMANIA MEXICANA AMAZONENSIS IN
LEISHMANIA RESISTANT C/57 MICE FOLLOWING
CONCOMITANT INFECTION WITH PLASMODIUM YOELII

Introduction

American cutaneous leishmaniasis (ACL) results from infection
with Leishmania mexicana or L.

braziliensis (Perez 1983).

hibits a wide spectrum of clinical symptoms.

ACL ex¬

In most instances the

infection consists of a spontaneously healing ulcerative lesion
(Barral et al.

1983).

However, non-ulcerative lesions which eventu¬

ally disseminate may occur (Perez et al.

1978).

It is believed that

the clinical manifestations of ACL reflect properties of the parasite
involved as well as genetic background and immunological competence
of the host (Hill 1986, Pearson et al.

1983).

Several murine models have been developed which mimic the di¬
verse symptoms of ACL.

Inbred C/57 mice normally develop localized

lesions which spontaneously heal,
ACL in humans.

similar to the most common forms of

On the other end of the spectrum, BALB/c mice exhibit

symptoms that are characteristic of disseminated ACL (Perez et al.
1979).

These strain differences purportedly reflect differences in

the genetic susceptibility of the host.
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We report here on the
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development of disseminated leishmaniasis in a Leishmania resistant
strain of mouse (C/57) following a non—lethal malaria infection.

Materials and Methods

Animals
C/57 mice were obtained from the Charles River Breeding Labora¬
tory, Wilmington, Massachusetts.

Malaria
Procedures for inoculating and quantifying P.

yoelii have been

described (Chapter 2).

Leishmaniasis
The Walter Reed strain 227 of Leishmania mexicana amazonensis
was used to infect mice.

Procedures for inoculating this parasite

have been previously described (Chapter 2).

After inoculation of L.

mexicana, the diameter of the infected footpad and the contra-lateral
uninfected footpad (control) were measured weekly with a direct read¬
ing vernier caliper.

Experimental design
Twenty mice were inoculated with L. mexicana only.

Ten addi¬

tional mice were inoculated intra-peritoneally with L. mexicana
followed by 1 x 106 Plasmodium yoelii infected RBC in 3 weeks.
Development of L. mexicana was quantified for each group of mice.
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Results

Lesion development in mice infected only with L. mexicana is
shown in Figure 14.

Lesion diameter peaked at about 8 weeks post¬

inoculation, with gradual healing of the foot thereafter.
ination to the contra-lateral footpad occurred.
been confirmed in numerous other experiments.

No dissem¬

This observation has
We have followed the

course of infection of L. mexicana in approximately 150 C/57 mice for
periods ranging from 1-1 1/2 years.

In none of these mice did any

visible dissemination of the parasites occur.
Footpad lesion size was greatly enhanced in those mice infected
with both L. mexicana and P. yoelii.

Mean maximum lesion size in

these mice peaked at 14-16 mm in diameter,
ter in mice infected only with L. mexicana.

compared to a 10 mm diame¬
Three of the mice in¬

fected with both P. yoelii and L. mexicana developed lesions which
reached a maximum diameter of 27 mm at 20 weeks post-inoculation.
Atrophy of the foot thereafter resulted in a decrease in measurable
lesion diameter,

but did not indicate healing had occurred.

All 3 of

these mice developed lesions in the contra-lateral uninfected footpad
at around 18 weeks post-inoculation (Figure 14).

Metastatic lesions

were also evident in the nasal and tail regions of 1 of these mice.
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Figure 14.
Footpad Diameter in mice infected with only
Leishmania mexicana (N = 20), and in 3 mice infected with both
Leishmania mexicana and Plasmodium yoelii that developed
disseminated lesions. L. mexicana was inoculated at week 0 and
P. yoelii at week 3.

Time (weeks)

« Experimental foot (dual infection)
O Control foot (dual infection)
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Discussion

Why some individuals develop disseminated ACL is not known.
Barrel et al.

(1983) found that a given parasite strain could cause

both diffuse cutaneous leishmaniasis and muco-cutaneous leishmania¬
sis.

They suggested that the clinical expression of the parasite was

determined by the host response.

Dissemination of the pathogen oc¬

curred only after mice were over a year old.
of cell-mediated immunity,

Progressive depression

as pointed out by Gardner (1980),

was

suggested as possibly contributing to disease manifestation at this
point.

Dissemination of L. mexicana in this study occurred when mice

were only 26 - 35 weeks old,

suggesting that deterioration of the

immune system did not play a role in parasite dissemination.

Failure

of immune mechanisms has also been suggested as a factor that could
lead to development of disseminated ACL (Hill 1986).
(1973) believed that pulmonary tuberculosis,
severe malnutrition,

Walton et al.

alone or combined with

could possibly breach immune defenses.

would precipitate invasion of mucosal tissue by L.

This

braziliensis after

years of latent infection.
Malaria is a well documented suppressor of immune function
(Lelchuk & Playfair I960, Lwin et al.

1982),

and numerous studies

have shown that malaria can enhance the course of concomitant infec¬
tions (Cook 1985, Krettli 1977,

Salaman et al.

1969).

Our results

suggest that concurrent infection with malaria has the potential to
change a normally trivial Leishmania infection into one with serious
consequences.

Chapter V

EFFECT OF CIMETIDINE, RANITIDINE, AND 2'-DEOXYGUANOSINE
ON THE DEVELOPMENT OF LEISHMANIA MEXICANA AMAZONENSIS
IN LEISHMANIA SUSCEPTIBLE BALB/C MICE AND IN
LEISHMANIA RESISTANT C/57 MICE

Introduction

Leishmaniasis is a disease infecting millions of people in
tropical and semitropical regions (Marinkelle 1980).

Infection in

vertebrate hosts is initiated through inoculation of flagellated
promastigote forms by the sand fly vector.

Promastigotes are taken

up by mononucleated phagocytic cells and differentiate into amastigotes, which function as obligate intracellular parasites

(Molyneux

& Ashford 1983).
Pentavalent antiraonials are the drugs most often used to treat
leishmaniasis.

Other compounds may be used when parasites respond

poorly to these agents (Rees et al.

1985).

Currently available

chemotherapeutic agents have a number of drawbacks,

including signif¬

icant numbers of treatment failures (Bryceson et al.
al.

1984),

occasional unexplained deaths (Rees et al.

tentially debilitating side effects (Peters et al.
1986).

New>

1985, Thakur et
1985),

1980,

and po¬

Thakur

safer and cheaper antilelshmanial agents are urgently

needed (Marsden et al.

1979, Peters et al.
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1980).
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Host defense against Leishmania is believed to be modulated by
cell-mediated immunity (Murray et al.

1986).

Recovery from infection

has been shown to be mediated by T cells in inbred strains of mice.
Production of macrophage-activating lymphokines by spleen cells is
important to the development of resistance (Coutinho et al.
Scott & Sher 1986).

Leishmania susceptible (e.g.,

1984,

BALB/c) mice char¬

acteristically exhibit a suppression of cell-mediated immune re¬
sponses (Liew et al.
mice,

1982, Murray et al.

1986).

In these non-cure

suppressor T cells may initiate anergy (Blackwell & Ulczak

1984, Nickol & Bonventre 1985a 1985b).
Modulation of immune response offers a potential means of con¬
trolling leishmaniasis.

Monoclonal antibodies against specific T

cell subsets have been used therapeutically to treat susceptible mice
infected with leishmaniasis (Titus et al.

1985),

and specific trans¬

fer of T cell populations has been shown to enhance delayed hypersen¬
sitivity responses to L. major (Lima et al.

1984).

A number of

agents are currently used to control various human diseases by modu¬
lating immune response (Bender et al.
1985, Osband et al.

1981).

1984, Bril et al.

1984,

Drews

Cimetidine is an H-2 histamine receptor

antagonist which can inhibit T suppressor cell function (Zapata Sirvent et al.

1985).

It also can enhance proliferative responses of

peripheral blood lymphocytes (Gifford et al.

I960).

Cimetidine has

been used successfully to control peptic ulcers (Brogden et al.
and tumors (Osband et al.

1981),

following burns (Bender et al.
tamine receptor antagonist,

1978)

and can restore suppressed immunity

1984).

Ranitidine is also a H2 his¬

but the central imidazole group found in
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cimetidine has been replaced with a furan ring,
been slightly modified (Henry et al.

1980).

and a side chain has

The result is a compound

which inhibits the binding of histamine to H2 receptors yet has
little affinity for other sites (Zeldis et al.

1983).

cell activity is also affected by 2'-deoxyguanosine.
by inhibiting the enzyme ribonucleotide reductase,
DNA synthesis in these cells (Bril et al.

T suppressor
This agent acts

thereby preventing

1984).

The purpose of this study was to determine if cimetidine,
tidine,

rani¬

and 2'-deoxyguanosine could be used to control L. mexicana

amazonensis infection in BALB/c mice.
(pentostam)

Sodium stibogluconate

is a widely used antileishmanial drug.

This agent was

therefore used as a baseline drug against which to compare the effi¬
cacy of these immuno-modulating agents.

Materials and Methods

Animals
BALB/c and C/57 mice were obtained from the Charles River
Breeding Laboratory, Wilmington, Massachusetts.

Eight-week-old

females weighing 25-30 g were used for all experiments.

Leishmaniasis
Walter Reed strain 227 of Leishmania mexicana amazonensis was
used.

The source and history of this isolate have been described

(Nolan et al.

1984),

as have methods for the purification and inocu¬

lation of parasites (Chapter 2).
donor mice.

The donor

Amastigotes were obtained from

was sacrificed and the infected foot
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amputated,

surface sterilized with 70% ETOH,

Ten-Broeck glass tissue grinder.

and homogenized in a

Amastigote viability was determined

by the method of Hodgkinson and Herman (1980) and the number of para¬
sites per unit volume calculated by using a Petroff-Housser bacterial
cell counting chamber.

The solution was adjusted with PBS to obtain

a final concentration of 102,
otes in 10 ul PBS.

103,

104,

105,

or 106 viable amastig-

Mice were infected by subcutaneously inoculating

10 ul of the appropriate solution into the ventral surface of the
right rear-footpad.

The thickness of the infected footpad was

measured weekly with a direct-reading vernier caliper.

Measurements

commenced 1 week prior to the inoculation of L. mexicana and contin¬
ued for 10 (BALB/c) or 20 (C/57) weeks.

Lesion diameter was ex¬

pressed as the thickness of the infected footpad in millimeters minus
the thickness of the contralateral uninfected footpad.

Drug treatment
Drug treatment commenced 1 day after inoculation of L. mexicana
into mice,

and was continued once daily for either 10 or 20 days.

Thereafter, mice were inoculated once a week until the conclusion of
the experiment.

Inocula were delivered in 0.5 ml PBS.

received only PBS.

Control mice

Experimental groups consisted of 10 (BALB/c mice)

or 20 (C/57 mice) animals.
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Experimental groups
Experiment i.

The BALB/c mice in this experiment received

either cimetidine (20 mg/kg/day) or pentostam (200 mg/kg/day) once
daily for 10 days.
Experiment ii.

The BALB/c mice in this experiment received

either cimetidine (40 mg/kg/day),

pentostam (200 mg/kg/day),

or 2'-

deoxyguanosine (40 mg/kg/day) once daily over a 20 day period.
Experiment iii.

BALB/c mice in this experiment were inoculated

with combinations of cimetidine (40 mg/kg/day) and pentostam (200
mg/kg/day),

cimetidine (40 mg/kg/day) and 2'—deoxyguanosine (40

mg/kg/day),

or pentostam (200 mg/kg/day) and 2'—deoxyguanosine

mg/kg/day).

The drugs were given once daily over a 20 day period.

Experiment iv.
10

(40

Eight groups of BALB/c mice were infected with

-* Mexicana amastigotes in this experiment.

Mice in each group

were treated with cimetidine or ranitidine in one of the following
doses:

40,

80,

160,

or 320 mg/kg/mouse/day.

A control group

received PBS.
Experiment v.
experiment.
10 ’

10 ’

Ten groups of BALB/c mice were used in this

Two groups of mice were each infected with 102,

or lt)6 viable L. mexicana amastigotes.

103,

One group of mice

infected with each inocula received either cimetidine or ranitidine
at a dose of 80 mg/kg/mouse/day.

Control mice for each treatment

received only PBS.
Experiment vi.

In this experiment,

two groups of C57 mice were

infected with 106 L. mexicana amastigotes and treated with either
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cimetidine or ranitidine (80 mg/kg/mouse/day).

A control group

received PBS.

Results

Experiment i
Results from the first experiment are shown in Fig.

15.

Lesions in mice which had received cimetidine or pentostam were
consistently smaller than the lesions in control mice.

The amount of

variation in lesion size within each group of mice was initally
small.

However,

the degree of variation increased markedly between 6

and 9 weeks post-inoculation in those mice treated with cimetidine.

Experiment ii
Increasing the dose of cimetidine or

2'-deoxyguanosine and/or

the duration of treatment resulted in the development of smaller
lesions than in control animals.

Cimetidine produced the most marked

therapeutic effect, whereas pentostam and 2'-deoxyguanosine resulted
in less impressive control (Fig.

16).

Experiment iii
All combinations of drugs were more effective at controlling
lesion development than were therapeutic regimes in which either pen¬
tostam or 2'-deoxyguanosine was used alone (Fig.

17).

However,

none

of the drug combinations which were tested were more effective at
controlling L. mexicana infections than cimetidine (Figs.

16 and 17).
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Experiment iv
Results from the fourth experiment are shown in Figs.
19.

Increasing the doses of both cimetidine (Fig.

(Fig.

18 and

18) and ranitidine

19) from 40 mg/kg/mouse/day to 320 mg/kg/mouse/day resulted in

a corresponding decrease in the diameter of lesions.
was observed,

No mortality

except in that group of mice receiving ranitidine at a

dose of 320 mg/kg/day.

Seven of the eight mice in this group died

within 2 h of the first drug treatment.

Significant lesion reduction

was observed as early as 4 weeks post-inoculation with both agents
(Figs.

18 & 19).

Complete resolution resulting from drug treatment

was not noted in any instance.

Experiment v
When the infective inocula of L. mexicana was increased a cor¬
responding increase in lesion diameter was observed (Figs.

20-24).

Neither cimetidine (80 mg/kg/day) nor ranitidine (80 mg/kg/day) had a
marked effect on lesion development in those mice infected with only
lo2 or 103 amastigotes (Figs.

20 & 21).

Cimetidine was more effec¬

tive than ranitidine when the infective dose consisted of 104
amastigotes (Fig.

22), while ranitidine was more efficient at limit¬

ing lesion development when mice were infected with 105 or 106
amastigotes (Figs.

23 & 24).

No mortality occurred in any of these

mice.

Experiment vi
The progression of L. mexicana amazonensis in BALB/c mice is
markedly different that that

normally seen in humans infected with

72

this pathogen.

In this respect C/57 mice provide a more realistic

model of human infection with the parasite.

Both cimetidine and

rantidine were effective at limiting the development of L. mexicana
in these mice (Fig.

25).

Lesions in both experimental groups were

smaller throughout the course of the infection,

and healing of

lesions occurred more rapidly in treated mice than in control mice
(Fig.

25).
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Figure 15.
Effect of cimetidine (20 mg/kg/day) and
pentostam (200 mg/kg/day) on the development of Leishmania
mexicana in BALB/c mice.
Drugs were given for a 10 day period
commencing 1 day after inoculation of L. mexicana ( + /- SE).

Time (weeks)
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Figure 16.
Effect of ciraetidine (40 rag/kg/day), pentostam
(200 mg/kg/day), and 2'-deoxyguanosine (40 mg/kg/day) on the
development of Leishmania mexicana in BALB/c mice.
Drugs were
given for a 20 day period commencing 1 day after inoculation of
L. mexicana (+/- SE).

Time (weeks)
76
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Figure 17.
Effect of cimetidine (40 mg/kg/day) and
pentostam (200 mg/kg/day), 2'-deoxyguanosine (40 mg/kg/day) and
pentostam (200 mg/kg/day), and cimetidine (40mg/kg/day) and
2'-deoxyguanosine (40 mg/kg/day), on the development of
Leishmania mexicana in BALB/c mice.
Drugs were given for a 20
day period commencing 1 day after inoculation of L. mexicana
(+/- SE).

Time (weeks)
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Figure 18. Effect of cimetidine (40, 80, 160, and 320
mg/kg/day) on the development of Leishmania mexicana
amazonensis in BALB/c mice.
Mice were infected with 10^
amastigotes at Week 0 (+/- SE).

control

TIME (WEEKS)
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Figure 19. Effect of ranitidine (40, 80, 160, and 320
mg/kg/day) on the development of Leishmania mexicana
amazonensis in BALB/c mice.
Mice were infected with 10^
amastigotes at Week 0 (+/- SE).

TIME (WEEKS)
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Figure 20. Effect of cimetidine and ranitidine (80
mg/kg/day) on the development of Leishmania mexicana
amazonensis in BALB/c mice.
Mice were infected with 102
viable amastigotes on Week 0 (+/- SE).

Time (weeks)

84

S!SBjUBlUlJS!0-| JO X0pu|

85

Figure 21. Effect of cimetidine and ranitidine (80
mg/kg/day) on the development of Leishmania mexicana
amazonensis in BALB/c mice.
Mice were infected with 10^
viable amastigotes on Week 0 (+/- SE).
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Figure 22. Effect of cimetidine and ranitidine (80
mg/kg/day) on the development of Leishmania mexicana
amazonensis in BALB/c mice.
Mice were infected with 104
viable amastigotes on Week 0 (+/- SE).

88

C\J

00

(X)

CM

O
S!SBjUBlUqS10“l JO X0pu|

Time (weeks)

o

89

Figure 23. Effect of cimetidine and ranitidine (80
mg/kg/day) on the development of Leishmania mexicana
amazonensis in BALB/c mice.
Mice were infected with 10
viable amastigotes on Week 0 (+/- SE).

Time (weeks)
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Figure 24. Effect of cimetidine and ranitidine (80
mg/kg/day) on the development of Leishmania mexicana
amazonensis in BALB/c mice.
Mice were infected with 10^
viable amastigotes on Week 0 (+/- SE).
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Figure 25. Effect of cimetidine and ranitidine (80
mg/kg/day) on the development of Leishmania mexicana
amazonensis in C/57 mice.
Mice were infected with 10^
viable amastigotes on Week 0 (+/- SE).

Time (weeks)
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Discussion

Mice infected with cutaneous leishmaniasis can be divided into
"healers" and "non-healers."

Specific immune responses control the

infection in "healers", whereas in susceptible mice suppressor T
cells abrogate potentially curative cell-mediated immunity (Howard et
al.

1980).

These results suggest that specific immunotherapy aimed

at T suppressor cells can provide control superior to that obtained
with pentostam in BALB/c mice.
Cimetidine,

an agent that inhibits T suppressor cell function,

can evidently affect the development of L. mexicana amazonensis in
BALB/c and C/57 mice.
the infection.

This control persisted through the course of

In most instances where the immuno—restorative effect

of cimetidine has been examined,

the development of a particular

disease was slowed rather than completely resolved (Osband et al.
1981, Gifford et al.

1981).

In no instance,

in Leishmania suscepti¬

ble or resistant mice, did cimetidine completely eliminate the devel¬
opment of clinical symptoms of cutaneous leishmaniasis,

supporting

these previous data.
Cimetidine affects the function of all cells bearing the H-2
histamine receptor (Zapata-Sirvent et al.

1985).

Ranitidine also

competitively inhibits the binding of histamine to H2-receptors;
ever, unlike cimetidine,

ranitidine purportedly does not bind to

other sites such as androgen receptors,
oxidase system,
such,

how¬

the hepatic mixed-function

or peripheral lymphocytes (Zeldis et al.

ranitidine should not effect immune function.

1983).

As

Although we have
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not examined the immunological response of ranitidine treated mice
during L. mexicana infections,

ranitidine was as effective as cimeti-

dine at limiting the development of clinical symptoms,

suggesting

that immunological cells might be affected by this agent.
2'-deoxyguanosine was less effective than cimetidine at con¬
trolling lesion development,

but more effective than pentostam.

deoxyguanosine inhibits replication of T suppressor cells,
not affect the activity of functional cells (Bril et al.

2'-

but does

1984), while

cimetidine affects the function of all cells bearing the H-2 his¬
tamine receptor (Zapata-Sirvent et al.

1985).

Reduction of T sup¬

pressor cell populations is presumably more complete with cimetidine
than with 2'-deoxyguanosine, possibly explaining the limited effect
of 2'-deoxyguanosine on development of lesions.
The BALB/c mouse provides a suitable model to study diffuse
cutaneous leishmaniasis (DCL); however,

the rapid development and

progression of lesions followed by fatal visceralization is atypical
of the majority of human infections (Perez et al.

1979).

None of the

agents we used to treat BALB/c mice were completely effective in lim¬
iting development of the parasite (Figs.

15-17).

In spite of this,

BALB/c mice proved ideal as an experimental host in which to compare
the efficacy of various agents at reducing the severity of Leishmania
derived lesions.

Differences in rates of lesion development result¬

ing from various drug regimes were easily quantified and significant
differences were routinely demonstrated.

Use of a mouse strain which

is somewhat more resistant to L. mexicana could provide additional
evidence on the beneficial effects of immuno-modulating agents.
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The effect of the infective dose towards parasite development
is often overlooked,

as is the role the infective dose has on the

efficacy of therapeutic agents.

Ranitidine and cimetidine were

examined under a variety of situations in this study.

Both cimeti¬

dine and ranitidine were most effective when extraordinary inocula
were used to infect mice.

When lower,

presumably more realistic,

doses of infective inocula were used (i.e.,

102 or 103 parasites),

the effect on lesion development was less dramatic.
Our results in both BALB/c and C/57 mice suggest that cimeti¬
dine and ranitidine have potential as antileishmanial agents.

Unless

an adequate immune response is mounted, muco-cutaneous and diffuse
cutaneous leishmaniasis often respond poorly to currently used thera¬
peutic regimes.

Combining agents which affect immune function,

such

as cimetidine, with currently used anti-leishmanial agents might
diminish the number of therapeutic failures experienced.

The wealth

of literature available on the chemistry, mode of action,

and side

effects of cimetidine increase the attractiveness of this agent
(Brogden et al.
cimetidine,

1978).

Although ranitidine is not as widely used as

a number of studies have indicated that the agent is a

more potent H2-receptor antagonist than cimetidine.

The attractive¬

ness of the agent is further augmented by the evident lack of compli¬
cating side-effects which may mitigate the efficacy of cimetidine.
In light of these results,

it is somewhat paradoxical that ranitidine

purportedly does not affect immune function (Zeldis et al.

1983).

Ranitidine clearly exhibited a curative effect on the development of
leishmaniasis in mice;

in most instances the drug was more effective
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than cimetidine as an anti-leishmanial agent.

However,

our results

do not indicate whether immune function was enhanced or whether the
agent acted in some other fashion.

In view of the limited number of

agents which are currently used to treat human leishmaniasis,
anti-leishmanial potential of cimetidine,

ranitidine,

guanosine should be examined in further detail.

the

and 2'-deoxy-

Chapter VI

THE EFFECT OF ANTI-LEISHMANIAL CHEMOTHERAPY ON THE
DEVELOPMENT OF LEISHMANIASIS (LEISHMANIA MEXICANA AMAZONENSIS)
AND CONCOMITANT MALARIA (PLASMODIUM YOELII)
IN LEISHMANIA SUSCEPTIBLE BALB/C MICE

Introduction

Many of the currently used chemotherapeutic agents inhibit
immune function,
Thong et al.

both in vivo and in vitro (Thong & Ferrante 1978,

1978 1979, Hanson 1981).

Many protozoan diseases,

including malaria and leishmaniasis, have well documented immunosup¬
pressive capabilities (Bruce-Chwatt 1985, Killick-Kendrick & Peters
1978, Molyneux & Ashford 1983).

The therapeutic use of agents which

compromise the immune system would only serve to exacerbate the
problem caused by parasite with known immunosuppressive function
(Ferrante & Goh 1984).

Accordingly, drugs used in the treatment of

specific diseases could be selected on the basis of their secondary
effects on immune function, not just on their antiparasitic activity
(Hanson 1981).
We have previously shown that concurrent infection with
Igishmania mexicana amazonensis can influence the development of
Plasmodium yoelii in BALB/c and C/57 mice (Chapters 2,
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3,

and 4).
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Although we have no direct evidence of this,

disease enhancement

which resulted from concomitant infection with these pathogens may be
due to the well documented immunosuppressive capabilities of these
parasitic protozoa (Killick-Kendrick & Peters 1978,
Murray et al.

1986).

Liew et al.

1982,

We have also demonstrated that agents which

modulate immune function can effectively be used to treat L. mexicana
infections in BALB/c and C/57 mice.

2'-deoxyguanosine,

cimetidine,

and ranitidine were as effective at limiting the development of lo¬
calized cutaneous lesions in these mice as pentostam,

a widely used

anti-leishmanial agent (Chapters 5 & 6).
This study was designed to assess the impact of pentostam and
cimetidine on the development of P. yoelii in BALB/c mice.

Plasmod-

ium y°elii infections were initiated in uninfected mice and in mice
which had been previously infected with L. mexicana.

Materials and Methods

Animals
Female BALB/c mice were obtained from the Charles River Breed¬
ing Laboratory, Wilmington, Massachusetts.

Mice were eight weeks old

and weighed 25-30 g when experiments were initiated.

Leishmaniasis
«

Walter Reed strain 227 of Leishmania mexicana amazonensis was
used.

The source and history of this isolate have been described

(Nolan et al.

1984),

as have methods for the purification and inocu¬

lation of parasites (Chapter 2).

Mice were infected with 1 x 106

101

amastigotes obtained from donor mice which had been infected 8 weeks
prior to the initiation of this experiment.

Progress of the infec¬

tion was determined on a weekly basis by measuring the diameter of
both rear feet with a direct-reading vernier caliper.

The size of

the lesion (in mm) was calculated by subtracting the measurement
obtained for the uninfected foot from that of the contralateral
infected foot.

Measurements commenced 1 week prior to the inocula¬

tion of L. mexicana and continued for 10 weeks.

Malaria
Procedures for the inoculation of experimental animals and the
quantification of P1asmodium yoe1ii parasitemia have been described
(Chapter 2).

All mice were infected with 1 x 106 infected erythro¬

cytes .

Drug treatment
Pentostam (200 mg/kg/day) and cimetidine (80 mg/kg/day) were
used.

Drug treatment commenced 1 day after the inoculation of para¬

sites and was continued once daily for 20 days.

Mice were thereafter

inoculated once a week until the conclusion of the experiment.
ula were delivered i.p.

in 0.5 ml phosphate-buffered saline

Inoc-

(PBS),

with control mice only receiving PBS.

Experimental groups
Two experiments were conducted.

Mice were treated with pento¬

stam in the first experiment and cimetidine in the second.
groups of 20 mice were used in each experiment.

Four

These groups
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consisted of:

1) uninfected mice,

mexicana infected mice,

2) P.

yoelii infected mice,

and 4) mice infected with both P.

L. mexicana (L. mexicana inoculated 1 day prior to P.

3) L.

yoelii and

yoelii).

Ten

of the mice in each group were treated with the appropriate
therapeutic agent.

The 10 remaining mice were treated with PBS and

served as controls.

Results

The effect of pentostam on parasite development is shown in
Figures 26—28.

Pentostam limited the development of cutaneous

lesions in mice which were only infected with L. mexicana and in mice
which were concurrently infected with P. yoelii (Fig.
ously demonstrated,

26).

As previ¬

treatment with pentostam did not "cure” any of

the mice which were infected with L. mexicana;

however,

the progres¬

sion of the disease was slowed in these animals.
Plasmodium yoelii infected mice that were treated with pento¬
stam developed malaria which was somewhat more severe than that in
untreated animals (Fig.

27).

The infection in these treated mice

peaked 10 days after pathogen inoculation, when 20% of all erythro¬
cytes were parasitized.

Parasites were cleared from the peripheral

circulation by day 16 of the infection.
Mice which were concomitantly infected with both P.

yoelii and

L. Sgxicana developed more severe malaria than did those mice which
were only infected with P. yoelii (Figs.

27 & 28).

Up to 30 % of all

103

RBC were infected ten days after parasite inoculation,

and the infec¬

tion was not cleared until 18 days post-inoculation.
Dually infected mice which were treated with pentostam devel¬
oped less severe P.

yoelii infections than did dually infected

animals which were untreated.

However,

the malaria in these treated

mice was more severe than that which developed in mice which were
only infected with P. yoelii (Figs.

27 & 28).

In Figure 28 the cumulative percent parasitemia in each group
of mice is plotted over time.

Differences in the course of parasite

development that are not clear when plotted in a normal fashion are
evident using this format. All animals which were treated with pento¬
stam developed more severe malaria than untreated P.

yoelii infected

mice.
Cimetidine limited the development of leishmaniasis in mice
infected with L. mexicana and in mice infected with both L. mexicana
and P. yoelii (Fig.

29).

The level of control observed with this

agent was comparable with that obtained using pentostam.
Plasmodium yoelii infected mice which were treated with cimetidine developed less severe malaria than untreated mice.

Parasites

were cleared from the peripheral circulation by 14 days post inocula¬
tion in these treated mice compared to 16 days in control animals
(Figs.

30 & 31).

—Xlcana and

Mice which were concurrently infected with both L.
developed significantly more severe malarial

infections than mice which were only infected with P. yoelii (Figs.
30 & 31).

When these dually infected mice were treated with cimeti¬

dine the severity of the Plasmodium infection decreased
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significantly,

both in terms of maximum observed parasitemia as well

as in the overall duration of the infection (Fig.

30).

By plotting

the cumulative percent parasitemia over time it is possible to
clearly visualize the effect cimetidine had on parasite development
(Fig.

31).
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Figure 26.
Effect of pentostara on the development of
Leishmania mexicana in i) mice infected with L. mexicana
only, and ii) in mice infected with both P. yoelii and L.
mexicana.
Parasites were inoculated at Week 0 (+/- SE).

*

Time (weeks)
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Figure 27.
Effect of pentostara on the development of
Plasmodium yoelii in mice infected with i) P. yoelii only,
and ii) in mice infected with both P. yoelii and Leishmania
mexicana.
Parasites were inoculated at Day 0 (+/- SE).

Time (days)
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Figure 28.
Effect of pentostam on the development of
Plasmodium yoelii in mice infected with P. yoelii only and in
mice infected with both P. yoelii and Leishmania mexicana:
Cumulative percent parasitemia as a means of differentiating
the effects of the drug on malaria.
Parasites were inoculated
at Day 0.

1 10
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Figure 29.
Effect of ciraetidine on the development of
Leishmania mexicana in i) mice only infected with L. mexicana,
and ii) in mice infected with both Plasmodium yoelTi and L.
mexicana.
Parasites were inoculated at Week 0 (+/- SE). ~~

Time (weeks)
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Figure 30.
Effect of ciraetidine on the development of
Plasmodium yoelii in mice infected with i) P. yoelii only, and
ii) in mice infected with both P. yoelii and Leishmania
mexicana.
Parasites were inoculated at Day 0 (+/- SE).
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Figure 31.
Effect of cimetidine on the development of
Plasmodium yoelii in mice infected with P. yoelii only and in
mice infected with both P. yoelii and Leishmania mexicana:
Cumulative percent parasitemia as a means of differentiating
effects of the drug on malaria.
Parasites were inoculated at
Day 0.

Time (days)

1 17

DISCUSSION

All forms of human leishmaniasis are initially treated with
either sodium stibogluconate (pentostam) or N-methyl glucanime
antimonate (glucantime)

(Berman 1985).

However,

treatment failure or

relapse occurs in approximately 10-25% of all cases where these
agents are used (Berman 1983).

Therapeutic doses of these pentava-

lent antimonials are occasionally associated with the development of
toxic side effects.
ineffective,

In cases where these pentavalent antimonials are

secondary treatment consists of either pentamidine or

amphotericin B.

Although these agents are usually effective,

utility is offset by their relatively high toxicity,
treatment regimen,
(Berman 1985).

their

the extended

and the unacceptably high cost of these agents

Because none of the currently used chemotherapeutic

agents are completely satisfactory,

intense efforts have been made to

develop more effective anti-leishmanial agents.

Hanson (1981)

suggested that the choice of a drug for the treatment of a specific
disease should be based not only on its antiparasitic activity but
also on its effect on immune function.
Although we did not directly examine immune function,

the

results of this study indicate that the secondary activity of a given
agent can affect the course of concomitant parasitic infections.
Pentostam has no known immuno-modulatory activity,
effective in the treatment of human leishmaniasis.

but is quite
However,

the use

of pentostam was associated with an increase in the severity of P.
Z°elii infections in BALB/c mice.

On the other hand,

cimetidine
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modulates T suppressor cell function by inactivating the H2 histamine
receptors on these cells.

Prior to this study,

effects of this agent had not been documented.

the antiparasitic
We have previously

shown that cimetidine is as effective as pentostam at limiting the
progression of L. mexicana in BALB/c mice.

Here we show that cimeti¬

dine is also somewhat effective at limiting P.
mice; moreover,

yoelii infection in

the ability of this agent to reduce the severe malar¬

ial infections that develop in mice concurrently infected with L.
mexicana was remarkable.
Numerous parasitic diseases are endemic in human populations
throughout the tropics.

Although reliable figures are not available,

infection with more than one pathogen is presumably a frequent occur¬
rence (Killick-Kendrick & Peters 1978).

Parasitic diseases are

usually treated with specific chemotherapeutic agents.

Most of the

currently used drugs exhibit functional activity against a specific
parasite or against a group of closely related parasite (Rollo 1980).
The effectiveness of a given agent is based on its ability to either
prevent the establishment of a specific pathogen in a susceptible
host or to eliminate a specific pathogen from an infected individual.
Little consideration is placed on the ability of a drug to influence
the course of incidental disease agents which might concomitantly or
subsequently infect the host.
Agents with known parasitic activity are occasionally tested
against unrelated organisms in an attempt to find new drugs for the
treatment of certain diseases.

Miconazole,

clotrimazole,

conazole were originally developed as antifungal agents;

and ketohowever,
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these agents also exhibit in vitro antileishmanial activity (Berman
1981).

The 8-aminoquinolines are frequently used in the treatment of

malaria.

Kinnamon et al.

(1978) showed that an 8-aminoquinoline (WR

6026) was highly effective against visceral leishmaniasis.

Chloro-

quine is widely used in the treatment of human malarial infections
(Bygbjerg & Flachs 1986, Herzog et al.

1983,

Rollo 1980).

In addi¬

tion to its antimalarial capabilities,

chloroquine has well known

anti-inflammatory properties (Rollo 1980) and can inhibit lymphocyte
proliferation (Bygbjerg & Flachs 1986, Gery & Eidinger 1977,
& Hirschhorn 1965, Panusch 1975,
Weatherall 1981).

Salmeron & Lipsky 1983,

Hurvitz

Trist &

Treatment with chloroquine has been associated

with poor antibody response to human rabies vaccine (Taylor et al.
1984),

and chloroquine has a demonstrable viral inhibitory effect

(Marsh et al.

1983).

Chloroquine, mefloquine,

and pyrimethamine are

known to inhibit human natural killer cell cytotoxicity (Ferrante &
Goh 1984).

Somewhat surprisingly,

similar studies with other

chemotherapeutic agents have rarely been conducted.
It is evident from this study that the choice of a chemothera¬
peutic agent can have important effects on both the primary pathogen
and on secondary parasites.

Given the presumed incidence of multiple

infections in human populations in the tropics,

greater emphasis

should be placed on determination of the parasite burden present in
each patient.
undertaken.

More appropriate therapeutic measures can then be

Chapter VII

INTERACTIONS BETWEEN MALARIA (PLASMODIUM YOELII) AND
LEISHMANIASIS (LEISHMANIA MEXICANA AMAZONENSIS):
AFFECT OF CONCOMITANT INFECTION ON PARAMETERS
AFFECTING DISEASE TRANSMISSION.

Introduction

Arthropod transmitted diseases depend on vector blood-feeding
behavior for transmission.

Initial contact with an infected host,

completion of an extrinsic pathogen incubation period,

and subsequent

feeding on a susceptible vertebrate are implicit to this process.
Factors which modulate any aspect of blood-feeding behavior can affeet pathogen transmission.
Mosquito engorgement patterns are often assumed to reflect in¬
nate cycles of "hunger" and preference for particular hosts
& Terapelis 1967, Tempelis et al.

1970).

However,

(Washino

evidence suggests

that feeding patterns may also be modulated by differences in host
defensive behavior (Edman & Kale 1971).

Many birds and rodents uti¬

lize various defensive regimes to prevent mosquitoes from success¬
fully engorging (Day & Edman 1984b, Edman & Kale 1971,
1974, Walker & Edman 1985 1986).

In spite of this,

mosquito-borne diseases are enzootic in these hosts,
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Edman et al.

a number of
suggesting that

121

some,

as yet unknown,

factor(s) allow mosquitoes to feed on these

animals.
Laboratory mice use various defensive movements to prevent
heraatophagous insects from obtaining blood.

Day and Edman (1983

1984b) and Day et al.

(1984) found that mice infected with Plasmodium

berghei, P.

or P. yoelii were less effective at preventing

chabaudi,

mosquitoes from obtaining blood than their uninfected counterparts.
Blood uptake occurred most frequently when gametocytes were preve—
lant.

Modification of host behavior by these parasites presumably

facilitates pathogen transmission.
We have previously shown that mice infected with both Leish-ania E£xlcana and P. yoelii develop more severe infections than mice
infected with either parasite alone (Chapters 2 and 3).

The purpose

of this study was to determine if concurrent infection with these
pathogens would affect host behavior.

Core body temperature,

daily

activity patterns and mosquito engorgement success were the parame¬
ters used to assay for behavioral modification.

Although Aedes

aeg^Eti is not a natural vector of either P. yoelii or L. mexicana,
it served as a bioassay with which to quantify behavioral changes in
mice infected with these pathogens.
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Materials and Methods

Animals
Female BALB/c mice were obtained from the Charles River Breed¬
ing Laboratory, Wilmington, Massachusetts.

Mice weighed 25-30 grams

and were 14 weeks old at the start of experiments.

Malaria
The 17x strain of Plasmodium yoelii was used.
the maintanence and inoculation of P.
(Chapter 2).

Procedures for

yoelii have been described

Mice were infected with 1 x 106 parasites.

Leishmaniasis
Leishmania mexicana amazonensis (Walter Reed strain 227) was
used.

"1*“”

“ ■1' I’“>- "

The source and history of this isolate have been described

“*

««

<“*«•■■ «.
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Mice

i„.ot.d wlth , ,

amastigotes.

Experimental design
g

ups of 15 mice each were used.

One group was sham in-

jected with 0.5 ml PBS and served as a control.
inoculated with P. yoelii.

A second group was

. third with L. mexicana,

and the fourth

with both P. yoelii and L. mexicana.

Determination of parasitemia
course of the malaria infection was monitored by determin¬
ing P. yoelii parasitemia in Giemsa-stained blood
smears (Chapter 2).
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Blood smears were prepared every two days until no parasites were
found over a six day period-

Daily percent parasitemia was plotted

for each group of mice infected with P.

yoelii.

Leishmania mexicana infections were monitored weekly by record¬
ing the thickness of the infected foot and the contralateral unin¬
fected foot using a direct-reading vernier caliper.

Measurements

commenced 1 week prior to the inoculation of L. mexicana and contin¬
ued throughout the course of the experiment.

The size of the lesion

was calculated by subtracting the measurement (in mm) obtained from
the uninfected footpad from that of the infected footpad.

Mean val¬

ues were recorded for each group of mice.

Mosquitoes
Aedes aegypti aegypti (L.)
in the laboratory at 27°C,

(Rockefeller Strain) were maintained

70-80X RH,

and a 16L:8D regime.

Cohorts

of 1,500 to 2,000 day-old mosquitoes were maintained in screened
cages.

Seven-day old mosquitoes from a given cohort were cold anes¬

thetized and sorted by sex.

Groups of 10 female mosquitoes were

placed in screen-topped, one-pint ice-cream cartons.

These cartons

served as holding cages prior to the commencement of experiments.
AH mosquitoes were provided with 3X sucrose.
ducted using 8 to 10 day old A.

Experiments were con¬

aegypti.

Mosquito feeding experiments
Aedes aegypti from the pint holding cartons were aspirated into
one gallon ice-cream containers with screened lids using a mechanical
aspirator.

Only water was provided while mosquitoes were in these
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containers.

Experiments commenced 24 hr after the introduction of

mosquitoes into the gallon containers.

All experiments were con¬

ducted late in the afternoon under fluorescent lights.
Experiments lasted 45 rain and were initiated with the introduc¬
tion of a single mouse into the cage.

Unrestrained (UR) mice and

restrained mice from each of the 4 experimental groups were used.

A

total of 7 trials each were conducted with UR mice which were unin¬
fected or which were infected with L. mexicana.
ducted with UR mice which were infected with P.

Ten trials were con¬
yoelii and 10 with

mice infected with both P. yoelii and L. mexicana.

Restrained mice

were anesthetized with nembutal (0.25 ml of a solution made up of 3
parts nembutal to 7 parts physiological saline)
introduction into the cage.
of the 4 experimental groups.

10 min prior to their

These mice served as controls for each
Preliminary data indicated that

mosquitoes fed equally well on restrained mice from each of the 4
experimental groups.

In light of this,

only 2 control trials were

conducted using restrained mice from each of the 4 experimental
groups and data from these 8 tests were pooled.
Mice were removed from the cages after 45 min and the mosqui¬
toes were aspirated back into the holding cartons using a mechanical
aspirator.

The surviving mosquitoes were killed by placing these

containers into a freezer,

and the mosquitoes were then counted and

checked for the presence or absence of blood.
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Activity cage experiments
Mice from each of the four experimental groups were individually placed in activity cages (Wahmann Manufacturing. Co.)*

Each

activity cage consisted of a wheel fitted with an automatic counter
which recorded each half revolution in either direction.

The daily

number of revolutions were recorded for each activity wheel during a
7 day control period and for a 3 week period following the inocula¬
tion of parasites.

The experiment was replicated 4 times.

The aver¬

age number of revolutions run by each group of mice was calculated
and plotted.

Core body temperature
A YSI electronic tele-thermometer fitted with an electronic
probe was used to monitor the core body temperatures of 10 mice from
each experimental group.

Temperatures were recorded every other day

over the course of the experiment.

Mean core body temperatures for

each group of mice were calculated and plotted.

Results

Determination of parasitemia

Mice which were inoculated with P. yoelii developed infections
in which approximately 15% of the RBC were infected during peak
parasitemia (Fig.

32).

Plasmodium yoelii parasitemia rates were

significantly enhanced when mice were concurrently infected with both
P. zoelii and L. mexicana.
fected in the

Approximately 35% of the RBC were in-

se mice during the height of the infection (Fig.

32).
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These results correspond with those previously obtained during exper¬
iments on dual infections in BALB/c mice (Chapters 2 and 3).
Mice infected with L. mexicana and P. yoelii did not develop
lesions which were significantly larger or smaller than those which
occurred in mice only infected with L. mexicana (because of this,
data for the progression of L. mexicana infection are not presented).
However, previous evidence (chapter 2)

indicated that lesions in

BALB/c mice only become detectable 3 weeks after parasite inocula¬
tion.

We have previously demonstrated that mice infected with both

L. mexicana and P. yoelii develop lesions which are significantly
larger than those lesions which occur in mice only infected with L.
mexicana (Chapters 2 and 3).

Such differences normally become de¬

tectable within 5 weeks of parasite inoculation.

Therefore,

it was

not surprising that differences in lesion development between these
two groups of mice were not detected.

Mosquito feeding experiments
The mean number of A.
is shown in Figs.

33-35.

aegypti remaining in each cage each day

More mosquitoes were recovered alive from

cages containing restrained mice than from cages containing unre¬
strained animals.

Although direct observations were not made,

it is

assumed that differences in mosquito mortality rates between control
and experimental cages resulted primarily from defensive movements of
unrestrained mice.
and ate mosquitoes.

Day (1981) reported that laboratory mice caught
Some mortality which occurred in cages which

contained unrestrained mice might have resulted from factors other
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than host defensive behavior.

Close examination of the cages occa¬

sionally revealed the presence of dead mosquitoes which were
"trapped" in excrement voided by unrestrained mice.

None of the re¬

strained mice produced urine or feces while anesthetized.

Although

we examined each cage for dead mosquitoes when the mice were removed
from the cages,

dead mosquitoes may have been consumed by the animals

prior to our examination.

It is therefore impossible to determine

the exact cause of observed mortality differences.
Mosquito engorgement success on mice from each experimental
group is shown in Figs.

36-38.

blood from uninfected mice (Fig.
L. mexicana (Fig.

37).

A.

aegypti were unable to obtain

36) or from mice infected only with

A small number of mosquitoes obtained blood

from mice infected with P. yoelii only.

Significant engorgement

rates only occurred during peak parasitemia;

however,

of the mosquitoes obtained blood during this period.
obtained blood from mice infected with both P.
(Fig.

38).

less than 20%
Mosquitoes also

yoelii and L. mexicana

Almost 50% of the mosquitoes which were exposed to dually

infected mice obtained blood during the period of peak parasitemia.
Again, mosquito engorgement only occurred during this period.

Activity cage experiments
The activity patterns of mice from each of the 4 experimental
groups are shown in Figs.

39-41.

The number of revolutions ran by

each mouse increased during the initial acclimation period (Figs 3941).

The animals presumably became accustomed to the activity wheels

during this time.

Uninfected mice normally ran at least 5,000
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revolutions per wheel per day (Figs.

39-41).

A great deal of varia¬

tion in daily activity occurred over the course of the experiment.
Mice infected with P. yoelii became less active as the infection pro¬
gressed.

These animals ran an average of 1,500 revolutions per day

during the peak of the infection.

Daily activity gradually increased

following clearance of the parasites from the peripheral circulation
(Fig.

39).

Mice infected with L. mexicana remained as active as the

uninfected mice throughout the experiment (Fig.

40).

The daily ac¬

tivity patterns of mice infected with both P. yoelii and L. mexicana
resembled those of mice only infected with P. yoelii;

however,

running on the activity wheel decreased almost entirely during peak
Plasmodium infection (Fig. 41).

This reduction in running was both

more pronounced and of a longer duration than changes which occurred
to mice infected with P. yoelii only.

Core body temperature
Uninfected mice maintained a core body temperature of approximately 36.5 - 37.0°C throughout the course of the experiment (Figs.
42-44).

Mice infected with L. mexicana initially maintained this

core body temperature.

However,

these mice gradually became hyper¬

thermic as the infection progressed.

The core body temperature of

these mice had stabilized between 37.5°C and 38.0°C at the conclusion
of the experiment (Fig. 43).

Mice infected with P. yoelu became

slightly hypothermic at the peak of the infection (Fig.

42) as did

mice infected with both P. yoelii and L. mexicana (Fig.

44).
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Hypothermia in dually infected mice was more pronounced than that
observed in mice infected only with P.

yoelii (Figs.

42 & 44).
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Figure 32.
Plasmodium yoelii parasitemia in BALB/c mice
infected with a) P. yoelii only (PYIM), and b) both P. yoelii
and Leishmania mexicana (DIM). Parasites were inoculated on Day
0 (+/- SE).

Time (days)
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Figure 33.
Mean number of Aedes aegypti remaining after
exposure to a) restrained mice (RM), b) unrestrained uninfected
mice (UR-UIM), and c) unrestrained Plasmodium yoelii infected
mice (UR-PYIM).
Parasites were inoculated on Day 0 (+/- SE).

Days Post-Inoculation
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Figure 34.
Mean number of Aedes aegypti remaining after
exposure to a) restrained mice (RM), b) unrestrained uninfected
mice (UR-UIM), and c) unrestrained Leishmania mexicana infected
mice (UR-LMIM).
Parasites were inoculated on Day 0 (+/- SE).

Days Post-Inoculation
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Figure 35.
Mean number of Aedes aegypti remaining after
exposure to a) restrained mice (RM), b) unrestrained uninfected
mice (UR-UIM), and c) unrestrained mice infected with both
Plasmodium yoelii and Leishmania mexicana (UR-DIM).
Parasites
were

inoculated on Day 0

(+/- SE).

Days Post-Inoculation
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Figure 36.
Feeding success of Aedes aegypti when exposed
to a) restrained mice (RM), b) unrestrained, uninfected mice
(UR-UIM), and c) unrestrained Plasmodium yoelii infected mice
(UR-PYIM).
Parasites were inoculated on Day 0 ( + /- SE).

Days Post-Inoculation
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Figure 37.
Feeding success of Aedes aegypti when exposed
to a) restrained mice (RM), b) unrestrained, uninfected mice
(UR-UIM), and c) unrestrained Leishmania mexicana infected mice
(UR-LMIM).
Parasites were inoculated on Day 0 (+/- SE).

Days Post-Inoculation
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Figure 38.
Feeding success of Aedes aegypti when exposed
to a) restrained mice (RM), b) unrestrained, uninfected mice
(UR-UIM), and c) unrestrained mice infected with both
Plasmodium yoe1ii and Leishmania mexicana (UR-DIM).
Parasites
were

inoculated on Day 0

(+/- SE).

Days Post-Inoculation
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Figure 39.
Mean daily activity of a) uninfected mice
(UIM), and b) Plasmodium yoelii infected mice (PYIM). Parasites
were inoculated on Day 0 (+/- SE).

Days Post-Inoculation
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Figure 40.
Mean daily activity of a) uninfected mice
(UIM), and b) Leishmania mexicana infected mice (LMIM).
Parasites were inoculated on Day 0 (+/- SE).

Days Post-Inoculation
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Figure 41.
Mean daily activity of a) uninfected mice
(UIM), and b) mice infected with both Plasmodium yoelii and
Leishmania mexicana (DIM).
Parasites were inoculated on Day 0
( + /- SE).

Days Post-Inoculation
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Figure 42.
Mean body temperature of a) uninfected mice
(UIM), and b) Plasmodium yoelii infected mice (PYIM).
Parasites were inoculated on Day 0 (+/- SE).

Days Post-Inoculation
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Figure 43.
Mean body temperature of a) uninfected mice
(UIM), and b) Leishmania mexicana infected mice (LMIM).
Parasites were inoculated on Day 0 (+/- SE).

Days Post-Inoculation
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Figure 44.
Mean body temperature of a) uninfected mice
(UIM), and b) mice infected with both Plasmodium yoelii and
Leishmania mexicana (DIM).
Parasites were inoculated on Day 0
(+/- SE).

Days Post-Inoculation
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Discussion

Numerous studies have shown that parasite manipulation of
host/vector interplay can result in facilitated pathogen transmission
(Molyneux & Jefferies 1986).

Parasites can affect the probing abil¬

ity of infected insects (Anez & East 1984,
et al.

1980, Rossignol et al.

1984),

Beach et al.

1985, Jenni

and certain arthropods locate

blood from infected hosts more rapidly than from uninfected animals
(Rossignol et al.

1985).

Pathogen-mediated alteration of host behav¬

ior can increase vector engorgement rates on parasitemic hosts (Day &
Edman 1984b, Day et al.

1983).

Day and Edman (1983) found that mosquitoes were less effective
at obtaining blood from mice infected with low virulence P.
than from either P. berghei or P.

chabaudi infected mice.

yoelii
Plasmodium

yoelii is often associated with a more virulent malarial infection in
naturally infected rodents (Carter & Walliker 1975, Killick-Kendrick
1978).

Day and Edman (1983) suggested that successful transmission

of P. yoelii might depend upon the manipulation of host behavior by
these associated parasites.

Transmission of P. yoelii might be fa¬

vored if the host were concurrently infected with any other pathogen
which modulates host defensive behavior (i.e.,
lent species or strain of P1asmodium).

not just a more viru¬

Even if the concomitant

pathogen did not directly influence host behavior, more mosquitoes
might successfully engorge on dually infected hosts if the presence
of a second parasite resulted in an enhanced malarial infection (as
shown in Chapters 2,

3,

and 4).
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Core body temperature, host activity patterns,

and mosquito

engorgement success were used to assay the effect of P.
mexicana on host health.

yoelii and L.

On the basis of these criteria,

P.

yoelii

and L. mexicana proved to be relatively benign parasites of labora¬
tory mice.

Neither parasite markedly affected core body temperature,

although mice infected with L. mexicana became slightly hyperthermic
by the conclusion of the experiment.

This is in contrast to the

slight hypothermia observed in mice infected with P. yoelii.

In no

instance did the hypothermia in these mice reach the low level
recorded in mice infected with P.

berghei or P.

chabaudi (Day & Edman

1984).
Mice infected with L. mexicana remained as active as uninfected
mice for the duration of the experiment.

Mice infected with P.

yoelii remained as active as uninfected mice for several days follow¬
ing parasite inoculation.

A drop in daily activity coincided with an

increase in parasitemia levels.

The clearance of parasites from the

peripheral circulatory system was associated with a rapid increase in
daily activity.

These alterations to daily activity were relatively

small compared to the effects produced by P.

berghei and P.

chabaudi

in laboratory mice (Day 1981).
Although core body temperature and host activity can be used to
assess host health, vector feeding success provides a more meaningful
measure of epidemiologically significant changes in host health.
Without blood uptake,
cannot occur.

subsequent transmission to a susceptible host

Although A.

aegypti is not a vector of either P.

Zoelii or L. mexicana; however,

it served to bioassay changes in host
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anti-vector behavior.

Mosquitoes were unable to obtain blood from

either uninfected mice or from mice infected with L. mexicana.
mosquitoes were able to engorge on mice infected with P.

A few

yoelii.

Successful feeding only occurred for several days during peak para¬
sitemia.

Whether the number of mosquitoes which obtained blood from

laboratory mice infected with P. yoelii would be sufficient to main¬
tain transmission of the disease under natural conditions is not
known.

Nor is it known if similar blood-feeding feeding patterns

occur in nature.

Little evidence is available to indicate what

proportion of mosquitoes must obtain blood in order for disease
transmission to continue.

However, under normal field conditions,

only a fraction of all mosquitoes which engorge will survive long
enough to transmit the parasite (Bruce-Chwatt 1985).
mosquitoes survive the sporogonic incubation period,

Even if
not all

mosquitoes will feed on susceptible hosts, nor will all cases of
mosquito feeding result in infection.

It is intuitive that the

larger the number of mosquitoes which successfully engorge,

the

larger the number which will survive to develop salivary gland infec¬
tion.

It is only these mosquitoes which are capable of parasite

transmission (MacDonald 1957).
Concurrent infection with P. yoelii and L. mexicana affected
all parameters which were examined.

Malarial infections in dually

infected mice were much more severe than in mice infected with P.
zoelii only.

The progression of L. mexicana was identical in both

groups of mice infected with that parasite.

Alteration of the vari¬

ous parameters which were examined in this experiment appeared to
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result from the abnormally severe malarial infection,
any variation in the progression of L. mexicana.

and not from

For example, mice

infected with P. yoelii became hypothermic and mice infected with L.
mexicana became hyperthermic.

All mice concurrently infected with

both parasites became severely hypothermic,

not hyperthermic.

Daily

activity patterns were also affected, with dually infected mice be¬
coming less active.
Profound pathological changes occur during malarial infections.
Erythrocyte destruction is accompanied by anemia and release of solu¬
ble substances into circulation.
leukocytes,

Endogenous pyrogen is released from

resulting in release of prostaglandins and monoamines

(Bruce-Chwatt 1985).

Parasitized cells develop "knobs" on their sur¬

face which interfere with circulation in the capillaries.

Resulting

oxygen depletion can lead to lesion development in various organs
(Bruce-Chwatt 1985).

Conversely, pathology resulting from cutaneous

leishmaniasis is primarily restricted to the site of lesion develop¬
ment (Molyneux & Ashford 1983).

Inoculation of promastigotes by sand

flies is followed by initial invasion of polymorphonuclear leuckocytes to the site of infection.
tion of cellular infiltration,

Ulceration results from a combina¬
edema,

and vasculitis leading to

disruption of blood supply and consequent necrosis.

Blood stream

dissemination only occurs in rare instances (Marsden & Jones 1985).
It is evident that malaria results in a systemic perturbation
of host physiological function (Killick-Kendrick & Peters 1978),
whereas cutaneous leishmaniasis affects localized tissue.
were infected with both P. Zoelii and L. mexicana developed

Mice which
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abnormally high malarial infections.

It is not surprising that

modification of host defensive behavior occurred during this period
of heightened P. yoelii parasitemia.
Although the model used to test the role of dual infection to¬
wards vector feeding success is artificial (i.e., L. mexicana is
found in South and Central America while P.
central Africa),

yoelii is distributed in

the results obtained in this study may be suggestive

of events in other epidemiological situations.

Numerous studies have

shown that disease enhancement can result from concomitant parasitic
infections (Killick—Kendrick & Peters 1978).

Modification of host

behavior during concomitant infection would presumably promote vector
feeding success in all instances where the host utilizes defensive
behavior to prevent blood uptake.

Chapter VIII

FEEDING BEHAVIOR OF LUTZOMYIA LONGIPALPIS
ON MICE INFECTED WITH LEISHMANIA MEXICANA AMAZONENSIS

Introduction

Leishmania mexicana is a major cause of cutaneous leishmaniasis
in South and Central America (Lainson & Shaw 1972).

Infection in the

vertebrate host is initiated through the inoculation of promastigotes
by sand flies.

The amastigote forms reside in macrophages and are

normally localized within discrete cutaneous nodules (Molyneux & Ash¬
ford 1983),
et al.

although dissemination of the parasites may occur (Perez

1979).

Sand flies become infected with L. mexicana by feeding

on areas rich in parasites.

Selective feeding on cutaneous lesions

would presumably facilitate transmission of L. mexicana.

although the

role of feeding site selection in infection of the vector has not
been examined.
Numerous studies have shown that host "defensive" behavior can
prevent mosquitoes from successfully feeding on birds (Edman & Kale
1971) and small mammals (Day & Edman 1984, Klowden & Lea 1979, Waage
& Nondo 1982, Walker & Edman 1986).

Day and Edman (1983) demon¬

strated that mice infected with malaria exhibited decreased anti¬
vector defensive behavior when gametocytes were most prevalent.
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This
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behavioral manipulation would favor transmission of the parasite.
Research on the role of host defensive behavior toward vector feeding
success has thus far been limited to mosquitoes (Day & Edman 1984,
Edman & Kale 1971, Klowden & Lea 1979, Waage & Nondo 1982, Walker &
Edman 1986) and Reduviid bugs (Schofield 1985,
1982,

Schofield et al.

1986).

Schofield & White

The effect of host behavior on sand

fly feeding success is not known, nor is the effect of Leishmania on
host behavior.
This study sought to determine whether sand flies preferen¬
tially fed on cutaneous lesions of mice infected with L. mexicana.
The role of host behavior on the feeding success of L.

longipalpis on

uninfected mice and on mice infected with L. mexicana was also deter¬
mined .

Materials and Methods

Animals
Female BALB/c mice were obtained from the Charles River Breed¬
ing Laboratory, Wilmington, Massachusetts.

Mice weighed 25-30 grams

and were 14-16 weeks old when used for experiments.

Leishmaniasis
Leishmania mexicana amazonensis (Walter Reed strain 227) was
used.

The source and history of this isolate have been described

(Nolan et al.

1984).

Eight-week old experimental animals were

infected, using procedures previously described, with amastigotes
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obtained from donor mice.

Mice were used for experiments 6-8 wks

after parasite inoculation.

Sand flies
Lutzomyia longipalpis (Lutz & Neiva) were reared using the
techniques of Modi and Tesh (1983).

Five-day old L.

long ipalpis were

aspirated out of adult holding cages and groups of 10 female flies
placed in 30x30x30 cm plexiglass observation chambers.

Flies were

provided with cotton pledgets soaked with a 30% fructose solution.
Fructose was removed after 24 hrs and only water provided.

Experi¬

ments commenced 24 hrs later, when the flies were 7 days old.

Observations
Individual mice were anesthetized with Nembutal and laid ven¬
tral surface down in the center of a cage containing 10 female L.
longipalpis.

The front feet of the mice were tucked under the body,

effectively preventing sand flies from feeding on these sites.
tential feeding sites therefore included:
tail,

Po¬

left and right hind feet,

eyelids (area of exposed skin around the eye),

ears,

and nose.

The total surface area of each of these sites was calculated (by
removing the skin from each site and spreading it over a grid) for
uninfected mice (UIM) and infected mice (IM).

All observations were

made in late morning and early afternoon under fluorescent light.
Statistical analyses followed methods of Snedecor and Cochran (1967).
Feeding site location.
exposed to groups of 10 L.

Twenty IM and 10 UIM were individually

longipalpis for 2 hrs.

individual flies successfully imbibed blood

Locations where

were recorded.
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Relationship of landing,
ing behavior of individual L.
IM.

probing and blood uptake.

The feed¬

longipalpis was observed on UIM and on

Observations commenced with initial landing of the fly on the

host and were continued until the flies left the host.
probing sites were recorded,
curred.

Foraging and

as were locations where blood uptake oc¬

Foraging sites were considered to be those areas of exposed

skin where individual flies spent periods of 1 sec or more.

Probing

sites consisted of areas where the mouthparts were actually inserted
into the skin, with or without blood uptake.
longipalpis for 2 hr periods.

Mice were exposed to L.

Twenty replicates (200 flies) were ob¬

served on UIM and 40 replicates (400 flies) on IM.
Duration of feeding.
L.

The length of time required by individual

longipalpis to feed to repletion on each area of exposed skin on

IM and UIM was determined.

Feeding duration was defined as the in¬

terval between the insertion of mouthparts into the skin of the host
and the withdrawal of mouthparts following blood uptake.

Feeding

bouts in which flies which withdrew the mouthparts prior to the
appearance of blood in the abdomen were not considered.

Feeding

duration was recorded for 25 flies on UIM and 25 flies on IM.
Role of host behavior towards sand fly feeding sucr.Pgg
of 10,

20,

30, 40,

50,

Groups

or 60 female flies were placed in holding

cages without water or fructose.

Experiments commenced 48 hours

later with the introduction of either an unrestrained or a restrained
BALB/c mouse (uninfected or infected with L. mexicana)
ing cage.

into the hold¬

Restrained mice were anesthetized with Nembutal and laid

ventral surface down in the center of the

cage.

Remaining L.
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longipalpis were aspirated from the cage after 1 hour and the number
of blood fed flies recorded.

Experiments were replicated 17 times on

uninfected mice and 8 times on infected mice.

Results

Feeding site location
Fifty flies were observed feeding on UIM and 127 on IM (Table
1).

Flies successfully fed on all areas of exposed skin on both UIM

and IM; however,

the selection of feeding sites was significantly af¬

fected by the disease status of the host (Table 1).

Flies exposed to

UIM showed no clear preference for particular feeding sites, while
flies feeding on IM fed predominantly on the infected foot.

Relationship of landing, probing and blood uptake
Fifty-six bouts were observed on UIM (Table 2) and 131 on IM
(Table 3).

Landing by L.

longipalpis was significantly correlated

with the total surface area of each site on both UIM (r=+0.96) and IM
(r=+0.92).

The high number of flies which landed on the infected

foot of IM was not greater than expected based on the total surface
area of the site (Chi-Square Goodness of Fit, P < 0.01).

This sug¬

gested that the selection of landing sites occurred randomly.
A small portion of all landings on UIM resulted in probing
(Table 2); however,

a greater percentage of flies probed on the eyes

of UIM mice than expected (Table 4).

Probing was much more frequent

on IM than expected (based on an equal probability of probing at all
sites).

The higher than expected incidence of probing on IM resulted
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from preferential probing on the infected foot (Tables 3 & 4).

A

corresponding decrease in the frequency of probing on the tail and on
the uninfected foot of the IM occurred.

Comparison of probing on UIH

with probing on IM demonstrated that observed differences in probing
behavior between groups were due almost entirely to this increase in
the incidence of probing on the infected foot of IM (Table 5).
Blood uptake occurred in 66.6% (8/12) of probes on UIM and 62.2%
(28/45) of probes on IM (Tables 2-4).

The uptake of blood was not

significantly different on the various sites on a mouse except for a
lower than expected frequency on the ears of IM),

nor between UIM and

IM (Tables 4-6).

Duration of feeding
The time required to feed to repletion by L.

longipalpis ranged

from 208 to 888 sec on UIM and 165 to 1669 sec on IM.

The mean time

required to feed to repletion on UIM and on IM did not differ greatly
(Table 7).

The length of time required to feed to repletion on par-

ticular sites varied considerably (Table 7).

Role of host behavior towards sand fly feeding auer.»««
Sand flies successfully fed on anesthetized mice,
able to feed on unrestrained animals (Tables 8-9).
-

The

but were unpresence of

—icana did not affect feedi"S success on either unrestrained or

restrained mice (Tables 8-9).
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Table 1.
Feeding site selection of female Lutzomyia
longipalpis on uninfected mice and on mice infected
with Leishmania mexicana amazonensis.

Uninfected Mice

Site

No.
Fed

% of
Total

Infected Mice
No.
Fed

% of
Total

X2 Testa

5.86 *

Ear

11

22

11

8.7

Eye

13

26

22

17.3

1.72 ns

Nose

2

4

3

2.4

0.35 ns

Tail

13

26

11

8.7

9.20 *

Lft. Ft.

6

12

8

6.2

0.16 ns

Rt. Ft.b

5

10

72

56.7

Totals -

50

100

127

100.0

31.82 ****

3.

Significant values indicate that the percentage of
flies feeding on specific sites on uninfected mice
was different than the percentage of flies feeding
on the same site on infected mice (X2 test for
equality of 2 multinomials).
b
Site of inoculation of L. mexicana in infected mice
*

P < 0.05;

****

- P < 0.00001;

ns

- not significant.
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Table 2.
Blood uptake by Lutzomyia longipalpis
in relation to landing and to areas where probing
occurred on uninfected mice.

Surface o
Area (cm )

Site

Ear

6.1

Eye

0.4

Nose

No. of Flies
Landing (%a)

12

(21.4)

No. of
Probes (%k)

2

No. Blood
Fed (%c)

(16.6)

1

( 8.3)

8 (14.2)

5 (62.5)

3

(37.5)

0.2

7 (12.5)

1

(14.2)

1

(14.2)

Tail

6.4

12 (21.4)

2 (16.6)

1

( 8.3)

Lft. Ft.

2.7

8 (14.2)

1

(12.5)

1

(12.5)

Rt. Ft.d

2.7

9 (16.1)

1

(11.1)

1

(11.1)

Totals -

18.5

12

(21.4)

8

(14.2)

56

- Percent of total landings on each site.
- Percent of landings on each site which resulted
in probing.
Percent of landings on each site which resulted in
blood uptake.
d - Corresponds to inoculation site of L. mexicana in
infected mice.

Table 3.
Blood uptake by Lutzomyia longipalpis in
relation to landing sites and to areas where probing
occurred on mice infected with Leishmania mexicana
amazonensis.

Site

Surface
Area (cm^)

No. of Flies
Landing (%a)

No. of
Probes (%b)

No. Blood
Fed (%c)

Ear

6.1

23 (17.5)

6 (26.0)

1

Eye

0.4

12 ( 9.1)

6 (50.0)

5 (41.6)

Nose

0.2

11

( 8.3)

2 (18.1)

1

( 9.0)

Tail

6.4

34 (25.9)

5 (14.7)

2

( 5.8)

Lft. Ft .

2.7

16 (12.2)

2 (12.5)

1

( 6.2)

Rt. Ft. d

6.1

35 (26.7)

24 (68.5)

18

(51.4)

45 (34.3)

28 (21.3)

Totals - 21.9

131

Percent of total landings on each site.
Percent of landings on each site which resulted
in probing.
Percent of landings on each site which resulted
in blood uptake.
- Site of inoculation of L. mexicana.

( 4.3)
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Table 4.
The conditional probability of probing (given
landing) by Lutzomyia longipalpis on uninfected mice and
on mice infected with Leishmania mexicana amazonensis.

Uninfected Mice
Feeding
Site

Probe

Infected Mice

No
Probe

X2 Testa

0.20 ns

6

17

0.49 ns

Probe

No
Probe

X2 Testa

Ear

2

10

Eye

5

3

9.35 *

6

6

1.43 ns

Nose

1

6

0.24 ns

2

9

1.51 ns

Tail

2

10

0.20 ns

5

29

7.85

Lft. Ft.

1

7

0.44 ns

2

14

3.85

Rt. Ft.b

1

8

0.67 ns

24

11

24.80

Totals -

12

44

45

86

*
*
****

Significant values indicate that the incidence of
probing was different than expected based on an
eq^ai probability of probing at each site
(X Test for equality of 2 multinomials).
b

Site of inoculation of L. mexicana in infected mice.

* - P < 0.05;

**** - p < 0.00001;

ns - not significant.

Table 5.
The conditional probability of blood uptake
(given probing) by Lutzomyia longipalpis on uninfected
mice and on mice infected with Leishmania mexicana
amazonensis.

Uninfected Mice

Infected Mice

Blood

No
Blood

Ear

1

1

0.13

Eye

3

2

0.008 ns

Nose

1

0

0.10

ns

Tail

1

1

0.13

ns

Lft. Ft.

1

0

0.10

ns

Rt. Ft.b

1

0

0.13

ns

Totals -

8

4

Site

X2 Test3

Blood

ns

No
Blood

X2 Test3

1

5

_
fc
6.11

5

1

1.31 ns

1

1

0.13 ns

2

3

1.18 ns

1

1

0.13 ns

18

6

3.57 ns

28

17

3i

Significant values indicate that the incidence of
blood uptake was different than expected based on
an^equal probability of blood uptake at each site
(X Test for equality of 2 multinomials).
b

Site of inoculation of L. mexicana in infected mice.

*

P < 0.05;

**** - P < 0.00001;

ns

- not significant.
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Table 6.
A Comparison of the probability of probing
(given landing) or the probability of blood uptake
(given probing) on uninfected mice with the probability
of probing or the probability of blood uptake on mice
infected with Leishmania mexicana amazonensis.

X2 Valueab

Site

- X

Probing vs.
Not Probing

Blood Uptake vs.
No Blood Uptake

Ear

0.44 ns

0.75 ns

Eye

0.31 ns

0.76 ns

Nose

0.04 ns

2.00 ns

Tail

0.02 ns

0.05 ns

Lft. Ft.

0.00 ns

2.00 ns

*

Rt. Ft.c

19.27

Totals -

20.10 *

2

0.47 ns

0.01 ns

for equality of proportions.

- Significant values indicate that probing or blood
uptake on infected mice was different than probing
or blood uptake on uninfected mice.
Site of inoculation of L. mexicana in infected mice.
- P <( 0.05;

ns - Not significant
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Table 7.
Duration of feeding of Lutzomyia longipalpis
on uninfected mice and on mice infected with Leishmania
mexicana amazonensis.

Duration of Feeding
On Uninfected Mice

Site

No.
Fed

Mean Time in secs
to Feed (+/-SE)

On Infected Mice
No.
Fed

Mean Time in secs
to Feed (+/-SE)

Ear

7

391

(52.5)

1

331

Eye

4

643

(66.4)

5

474 (116.2)

Nose

—

—

Tail

6

575

Lft. Ft.
Rt. Ft.a

\

1

165

(52.8)

1

749

4

442 (117.0)

4

779 (166.7)

4

469 (143.6)

13

573 (105.8)

488

25

569

Totals - 25

—

(38.2)

Site of inoculation of Leishmania mexicana in
mice.

(68.4)

infectpH
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Table 8.
Comparison of the feeding success of Lutzomyia
longipalpis on restrained mice and on unrestrained
uninfected mice.

Host
Condition

Restrained

Unrestrained

Sand fly
Group
Size

No. of
Tests

No. of Flies
Blood Fed (?)

0-10

2

3/ 15

(20.00)

11-20

10

91/177

(51.41)

21-30

3

42/ 74

(56.75)

31-40

0

41-50

1

25/ 42

(59.52)

51-60

1

26/ 55

(47.27)

Total

17

187/363

(51.51)

0-10

2

0/ 17

(0.00)

11-20

10

2/175

(1.14)

21-30

2

1/ 75

(1.33)

31-40

2

0/ 75

(0.00)

41-50

0

—

—

51-60

0

—

—

Total

17

—

3/342

—

(0.87)
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Table 9.
Comparison of the feeding success of Lutzomyia
longipalpis on restrained mice and on unrestrained mice
infected with Leishmania mexicana amazonensis.

Host
Condition

Restrained

Unrestrained

Sand fly
Group
Size

No. of
Tests

No. of Flies
Blood Fed (%)

0-10

0

11-20

6

58/108

(53.70)

21-30

2

23/ 48

(47.91)

Total

8

81/156

(51.92)

0-10

0

11-20

7

2/125

(1.60)

21-30

1

0/ 22

(0.00)

Total

17

2/147

(1.36)

—

—

—

—
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Discussion
Feeding site location
Lutzomyia longipalpis fed randomly on UIM in this study.

The

feeding behavior of this fly appears to be similar to that of mos¬
quitoes, which land and forage indiscriminately on small rodents and
racoons (Magnarelli 1979, Walker & Edman 1985).

This is in contrast

to the specific landing site selection shown by some Tabanidae on
cattle (Hollander & Wright 1980, Magnarelli & Anderson 1980, Mullens
& Gerhardt 1979).

When L. longipalpis fed on mice infected with L.

g^lcapa the? Preferentially fed on the cutaneous lesions of the ani¬
mals.

No attempt was made to determine if the selection of specific

feeding sites resulted from differential landing, probing or blood
uptake rates, nor were actual infection rates determined.

In spite

of this, selective feeding on these parasite-rich areas by L.
longipalpis could clearly result in increased vector infection rates.
Certain sand flies have limited access to blood in normal human
skin, due to the shortness of the labrum compared to the thickness of
the epidermis (Lewis 1987).

In patients with post kala-azar dermal

leishmaniasis, parasites are often concentrated in cutaneous nodules
(Sen Gupta 1964, Indian Council of Medical Research 1980).

The epi¬

dermis in these nodules is greatly effaced, with the blood vessels
dilated in the superficial dermis (Sen Gupta & Bhattachargee 1953).
Lewis (1987) suggested that Phlebotomus argentipes should be able to
locate blood, and hence parasites, more easily from these nodules
than from normal skin.
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BALB/c mice infected with L. mexicana develop lesions in which
the epidermis is greatly distended.

Increased feeding on these

lesions by L. longipalpis could have resulted from:

1) an increase

in landing on the lesion (compared to the uninfected foot) due to the
increased surface area of the lesion, 2) an increase in the attrac¬
tiveness of the lesion for L. longipalpis, 3) selective probing on
the lesion once flies had landed, or 4) more successful blood uptake
on the lesion.

These possibilities were examined in greater detail

in subsequent experiments.

Relationship of landing, probing and blood uptake
The increased blood uptake by L. longipalpis on IM resulted
entirely from differences in the probing behavior of the flies on
these mice.

Lutzomyia longipalpis exhibited no clear preference for

landing on lesions, nor was uptake of blood more efficient at these
sites once probing was initiated.

Probing occurred more frequently

on the infected foot of IM than on all other areas, with the exception of the eyes of UIM and IM.
Numerous studies have shown that the manipulation of hostvector interactions by parasites can facilitate pathogen transmission
(Molyneux & Jefferies 1986).

Enhanced disease transmission can re¬

sult from changes in the probing ability of infected insects (Anez &
East 1984, Beach et al. 1985, Jenni et al.

1980, Rossignol et al.

1984), from increased blood finding success of arthropods on parasitemic hosts (Rossignol et al. 1985), and from changes in the
efficacy of defensive behaviors of infected animals (Day & Edman
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1983).

Rossignol et al.

(1985) found that blood uptake was facili¬

tated in animals infected with Plasmodium chabaudi or Rift Valley
fever virus once probing was initiated.

We suggest that pathological

changes in the epidermis produced during L. mexicana infections may
also result in enhanced disease transmission (due to increased feed¬
ing on those areas where parasites are usually found).
report by Rossignol et al.

Unlike the

(1985); however, these data suggest that

facilitated blood uptake may result from factors that come into play
prior to the initiation of feeding.

The precise mechanism by which

this occurs is not known.

Duration of feeding
Blood-feeding insects face certain risks during host contact
(Gillet 1967, Rossignol et al.

1985).

The predicted strategy for

blood-feeding insects therefore consists of a maximization of nutri¬
ent intake rate and a minimization of time required to obtain a blood
meal (Daniel & Kingsolver 1983).
In contrast to reports on rapid feeding by mosquitoes (Mellink
et al. 1982, Walker & Edman 1986) and by the sand fly, Lutzomvia
Orestes (Mendoza et al.
both IM and UIM.

1983), L. longipalpj, fed extremely slowly on

Based on feeding speed alone, blood feeding by this

fly appears to be a relatively inefficient process.

A combination of

Slow feeding by the vector and host defensive behavior may have
contributed to the inability of L. loalpalpi. to feed on both unre¬
strained UIM and unrestrained IM in these experiments.
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Many vertebrates possess behavioral repertoires which limit the
duration of host/vector contact (Day & Edman 1984, Edman & Kale 1971,
Waage & Nondo 1982, Walker & Edman 1986).

Rossignol et al.

(1985)

suggested that mutualism between parasite and vector could result in
a decrease in the duration of feeding, thereby favoring parasite up¬
take.
al.

Unlike P. chabaudi and Rift Valley fever virus (Rossignol et

1985), Leishmania mexicana does not appear to affect vector feed¬

ing speed.

Role of host behavior towards sand fly feeding success
Day and Edman (1984) found that laboratory mice were highly
defensive towards Aedes aegypti, Anopheles quadrimaculatus, Culex
—ipalpisi and Culex quinquefasciatus.

Unrestrained mice prevented

mosquitoes from successfully feeding in most instances.

We have

found that unrestrained mice were equally as defensive towards L.
longipalpis, allowing only a small portion of all flies to feed.
This is the first demonstration that the blood feeding success of
Diptera other than mosquitoes is affected by host defensive re¬
sponses.

Infection with L. mexicana did not affect host defensive

behavior towards sand flies.

Although L. mexicana infections in

BALB/c mice appear debilitating, transmission is not favored by a
manipulation of host behavior.

Feeding Behavior of Lutzomyla longipalpis on mice
Transmission of arthropod-borne diseases depends on the suc¬
cessful uptake of pathogens by a vector.

When parasites are local¬

ized in discrete areas, as with New World cutaneous leishmaniasis,
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preferential selection of feeding sites could result in increased
vector infection rates.

Pathogens which are systemically distributed

presumably would not be affected by feeding site selection.

Analysis

of data suggests that factors associated with L. mexicana infections
in BALB/c mice contribute to feeding on those areas where parasites
presumably are most frequent.

We have not attempted to determine if

preferential feeding site selection would be reflected in actual sand
fly infection rates.

I

Chapter IX

SUMMARY OF CONCLUSIONS

The following conclusions were obtained during this study:

1) BALB/c and C/57 mice infected with Plasmodium yoelii developed an
infection that lasted 14-16 days.

Peak parasitemia occurred

approximately 10 days after parasite inoculation, when 10-15%
of all erythrocytes were infected.
2) BALB/c mice infected with Leishmania mexicana amazonensis devel¬
oped lesions at the site of inoculation.

Parasites rapidly

disseminated throughout the body of these mice.

Lesions devel¬

oped more rapidly when the infective inocula was increased;
however,

the outcome of the infection was consistent irregard—

less of the infective dose.
3) C/57 mice infected with L. mexicana amazonensis developed cuta¬
neous lesions at the site of inoculation.

The size of the

lesions increased gradually until they reached a maximum
diameter 10-15 weeks after parasite inoculation.
healing occurred thereafter.

Gradual

No parasite dissemination was

observed.
4) Mice infected with both P. yoelii and L. mexicana developed malar¬
ial infections which were more severe than those observed when
mice were only infected with P. yoelii.
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Twenty to 35% of all
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erythrocytes were infected during peak P.
these dually infected mice.

yoelii parasitemia in

Infections were enhanced when:

i)

both parasites were inoculated within 2 days of each other,

ii)

when L. mexicana was inoculated 3 weeks prior to P.

and

yoelii,

iii) when L. mexicana was inoculated 12 weeks prior to P.
yoelii.
5) BALB/c and C/57 mice infected with both P.

yoelii and L. mexicana

amazonensis developed Leishmania infections which were more
severe than those observed when mice were only infected with L.
mexicana.

Mice infected with both P. yoelii and L. mexicana

developed lesions which were significantly larger than those in
control mice when:

i) both parasites were inoculated within 2

days of each other,

ii) when L. mexicana was inoculated 3 weeks

prior to P. yoelii,

iii) when P.

prior to L. mexicana,

yoelii was inoculated 3 weeks

and iv) when P.

yoelii was inoculated 12

weeks prior to L. mexicana (C/57 mice).
6) Several C/57 mice which were infected with both P.

yoelii and L.

mexicana developed disseminated lesions which did not heal
spontaneously.

As previously stated,

such dissemination was

never observed in mice only infected with L. mexicana.
7) Infection with Plasmodium or Leishmania is associated with a well
documented suppression of immune function.

The enhanced para¬

sitemia that resulted from infection with both P.

yoelii and L.

mexicana presumably results from these immunosuppressive ef¬
fects.

Drugs which affect immune function could theoretically

be used to treat these infections.

Agents which modulate T
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suppressor cell function were used in an attempt to treat L.
mexicana infections in BALB/c and C/57 mice.

Cimetidine and

2'-deoxyguanosine were as effective as pentostam (an agent with
known anti-Leishmanial activity) at controlling lesion develop¬
ment in these mice.

Varying the infective dose used to initi¬

ate infections affected the capacity of these drugs to treat
clinical symptoms.

Further research on the capacity of immune

modulation for the treatment of leishmaniasis is warranted.
8) Treatment with pentostam resulted in more severe malaria in mice
only infected with P. yoelii and in mice infected with both P.
yoelii and L. mexicana.
9) Cimetidine limited the development of L. mexicana in mice infected
with this parasite alone and in mice concurrently infected with
P. yoelii.

Cimetidine did not affect the development of P.

y°elii in mice only infected with that parasite;

however,

P.

y°elii infection was markedly limited in mice concurrently
infected with L. mexicana.

This indicated that manipulation of

one infection (L. mexicana) effectively limited the development
of a concomitant pathogen (P. yoelii).

Such control presumably

resulted from the immuno-modulatory effects of cimetidine.
10) BALB/c mice were extremely efficient at preventing blood seeking
mosquitoes (Aedes aegypti) from feeding.
11) Mosquitoes which were exposed to mice infected with P. yoelii
were only able to engorge during a 3-4 day period.

This

increase in feeding success was associated with the period of

184

maximum parasitemia.

Very few mosquitoes ever obtained blood

from uninfected mice or from mice infected with L. mexicana.
12) Significantly more mosquitoes engorged on mice infected with both
P. yoelii and L. mexicana than on uninfected mice,
infected with L. mexicana,

on mice only

or on mice only infected with P.

yoelii.
13) Uninfected mice maintained a core body temperature of approxi¬
mately 36.5-37°C

Mice infected with L. mexicana became hyper¬

thermic by the conclusion of the experiment, with the mean
daily temperature rising gradually to 38°C.

Mice infected with

P. yoelii or with both P. yoelii and L. mexicana became hypo¬
thermic during the crisis phase of P.

yoelii infection.

mean core body temperature of mice infected with P.

The

yoelii or

dropped to 36.2°C, while that of mice infected with both P.
yoelii and L. mexicana dropped to 34.1°C.
14) The daily activity of uninfected mice and L. mexicana infected
mice remained constant over the course of the experiment
(approximately 5,000 revolutions per day on each activity
wheel).

Mice infected with P. yoelii or with both P.

yoelii

and L. mexicana were less active during peak malarial infection
than at other times.
15) Sand flies (Lutzomyia longipalpis) were unable to feed on unre¬
strained, uninfected mice or on unrestrained,
fected mice.

L. mexicana in¬

Sand fly engorgement was prevented by defensive

movements of these animals.
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16) Lutzomyia longipalpis were able to feed on restrained mice.
Flies preferentially fed on the cutaneous lesions of mice
infected with L. mexicana.

This preference resulted from

selective probing on the lesions,

and not from a non-random

choice of landing site nor from facilitated blood uptake once
probing had commenced.

Outbreaks of leishmaniasis have historically followed epidemics
of malaria in certain geographical areas (Pampiglione et al.

1974).

This temporal coincidence presumably results from the increased
production of mosquitoes and sand flies during periods of favorable
environmental conditions (Pampiglione et al.

1974).

of vector abundance towards the epidemiology of

The importance

these diseases was

highlighted during the World Health Organization's malaria eradica¬
tion campaign.
the campaign,

Following the widespread application of DDT during
the incidence of leishmaniasis (Corradetti 1952,

1949, Lysenko 1971, Nadim & Araini 1970,

Hertig

Seyedi-Rashiti & Nadim 1975)

and other Phlebotomus-borne diseases (Hertig 1949, Hadjinicolaou
1958, Tesh & Papaevangelou 1977) dropped markedly in areas where the
pesticide was sprayed.

This decrease presumably resulted from the

elimination of endophilic sand flies by the pesticide.
Although sand fly abundance may be the most important factor
contributing to the development of epidemic leishmaniasis,
tors may also be relevant.

other fac-

Pampiglione (1974) suggested that stress

such as epidemic malaria or famine would affect the competence of the
host immune system.

This perturbation would transform an otherwise
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inapparent Leishmania infection into a clinically evident case.
Evidence has shown that clinically apparent cases of leishmaniasis
comprise a small fraction of all infections (Esterre et al.
Fuller et al.

1976 1979, Pampiglione et al.

1974),

1987,

suggesting that

some unknown factor(s) affect the progression of the parasites in the
host.
The immunological competence of an organism is crucial to the
epidemiology of all infectious diseases.

The nutritional state of

the host and the presence or absence of concomitant infections are
key factors which can modulate immune competence (Harrison et al.
1986, Dowd & Heatley 1984, Killick-Kendrick & Peters 1978).
development of protective immunity to L. mexicana and L.
clearly affected by protein malnutrition (Harrison et al.
et al.

1984),

The

donovoni is
1986,

Perez

and there appears to be a reciprocal relationship

between undernutrition and the development of visceral leishmaniasis
(Harrison et al.
lione et al.

1986).

Although Walton et al.

(1973) and Pampig¬

(1974) suggested that tuberculosis or malaria might

affect the course of a Leishmania infection,

little research has been

directed towards the role concomitant infections might have on the
development of the disease.
These results clearly demonstrate the effects concomitant infection with Plasmodium zoelii and Leishmania mexicana amazonensis
can have in laboratory mice.

Not only were the clinical symptoms of

each disease enhanced during dual infections,

but factors which af¬

fect vector feeding success (and thereby disease transmission) were
altered.

Although the combination of Leishmania mexicana and
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Plasmodium yoelii in BALB/c mice is an artificial system,

the results

obtained during this study may be applicable to other, more realis¬
tic,

epidemiological situations.
Perturbation of the host immune system may been responsible for

the disease enhancement which occurred in mice infected with P.
yoelii and L. mexicana.

It seemed plausible that agents which

modulate immune function might be effective against Leishmania or
Plasmodium infections.
tidine,

We examined the effects of cimetidine,

rani¬

and 2'-deoxyguanosine on the development of leishmaniasis in

BALB/c and C/57 mice.

Cimetidine and ranitidine inhibit the activity

of T suppressor cells by binding to the H2 histamine receptor
(Zapata-Sirvent et al.

1985, Henry et al.

1980), while 2•-deoxyguano-

sine inhibits the replication of these cells (Bril et al.

1984).

Each of these agents limited the development of lesions in BALB/c
mice.

The control was comparable to,

using pentostam.

However,

or better,

than that obtained

in no instance did any of these three

agents completely eliminate all symptoms of the disease.
are in agreement with those of Osband et al.
al.

These data

(1981) and Gifford et

(1981), who found that the immuno-restorative effect of cimeti-

dine slowed the development of a given disease rather than eliminat¬
ing all symptoms.

Mucocutaneous and diffuse cutaneous leishmaniasis

respond poorly to chemotherapy unless an effective immune response is
initiated.

Use of agents that activate immune function may have

great value for the treatment of these forms of leishmaniasis.
Further research on the therapeutic effects of immuno modulating
agents against infectious diseases is certainly warranted.
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Very few studies have examined the influence that a chemothera¬
peutic agent aimed at one parasite can have on the development of
concomitant pathogens.

The system we have been using proved to be an

ideal model with which to examine this issue.

The results clearly

indicated that the agents used to treat one disease can have an
effect on the progression of an unrelated pathogen.
drug of choice for the treatment of leishmaniasis.
effective,

cheap,

Jones 1985).

Pentostam is the
It is fairly

and the side-effects are normally mild (Marsden &

Based on our studies with laboratory mice,

caution

should be exercised when treating patients who might also have
malaria.

Mice that were infected with P. yoelii and were treated

with pentostam developed more severe infections than control mice.
When pentostam was used to treat the Leishmania infection in mice
infected with both P. yoelii and L. mexicana,

the malaria was less

severe than the infection in control mice infected with both para¬
sites.

However,

this infection was still more severe than that in

control mice that were only infected with P.

yoelii.

Cimetidine

proved to be as effective as pentostam at limiting the development of
leishmaniasis in BALB/c mice.

However,

all mice treated with cimeti¬

dine (including those concurrently infected with P.

yoelii and L.

mexicana) developed malarial infections which were less severe than
that observed in control animals.

These results clearly indicate

that prior to the initiation of chemotherapy,

considerable care

should be taken to determine what concomitant parasites infect a
given host.

It is evident that chemotherapeutic agents may adversely

affect host health in some instances.
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Vector-borne diseases depend upon vector contact with an
infected host and,
period,

following an appropriate extrinsic incubation

subsequent feeding on a susceptible organism.

Previous

research has shown that rodents and certain birds use defensive
movements to prevent mosquitoes from engorging (Day & Edman 1984b,
Edman & Kale 1971, Edman et al.

1972 1974, Walker & Edman 1986).

& Edman (1983) found that infection with P.

berghei or P.

Day

chabaudi

affected host behavior so that vector feeding success was facili¬
tated.

However,

infection with P. yoelii did not significantly

affect host behavior.

Mosquitoes attempting to feed on mice infected

with P. yoelii were much less successful at engorging than on mice
infected with P.

berghei or P.

chabaudi (Day & Edman 1983).

We have shown that mice concurrently infected with P.

yoelii

and L. mexicana develop more severe malaria than that which occurs in
mice only infected with P. yoelii.

Aedes aegypti were only success¬

ful at feeding on these dually infected mice during the crisis phase
Plasrnodium infection.

These mosquitoes were unable to engorge

on uninfected mice or on mice infected with L. mexicana.

Very few A.

^Y?ti were able to feed on mice only infected with P. yoelii.

The

other parameters which were examined were also significantly affected
in mice infected with both parasites.

The mean core body temperature

and the mean amount of daily activity dropped markedly during the
crisis phase of the malarial infection in mice infected with both P.
^elil and -* gexicana.

These parameters were also affected in mice

only infected with P. yoelii; however,

the level of daily activity
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and the mean core body temperature decreased to a lesser degree than
that observed in dually infected mice.
The behavioral and physiological changes which were noted in
dually infected mice resulted from the increased severity of the
Plasmodium infection.
other groups of mice,

No comparable changes were noted in any of the
although similar,

occurred in mice only infected with P.

but less marked,

changes

yoelii.

It appears that mosquitoes would engorge more frequently on
rodents concurrently infected with P. yoelii and a Leishmania sp.
than on mice infected with either parasite alone.

Malarial transmis¬

sion would presumably be facilitated by this selective process.

The

transmission of leishmaniasis might also be favored by concurrent
infection with these pathogens,

as mice are extremely effective at

preventing sand flies from engorging.
swered; however,

This possibility remains unan¬

as rodents serve as the primary reservoir for many

forms of leishmaniasis,

this issue is especially relevant.

Cutaneous leishmaniasis is unusual among parasitic diseases in
that the pathogens are restricted to localized sites.

Vectors

presumably become infected by feeding on these parasite rich areas.
Lutzomyia longipalpis selectively fed on the lesions of anesthetized
L. mexicana infected mice.

This preferential selection of feeding

site did not result from discrimination during landing.

However,

once landing had taken place,

the flies probed more frequently on

lesions than on other sites.

The probability of successfully obtain¬

ing blood once probing had commenced was equal on all sites.

This
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selective process presumably facilitates the transmission of leishma¬
niasis .
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